<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Naloxone</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Naloxone">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Naloxone</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Naloxone</b>, sold under the brand name <b>Narcan</b> among others, is a medication used to block the effects of opioids.<span class="mw-ref" id="cite_ref-AHFS2015_4-2"><a href="#cite_note-AHFS2015-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is commonly used to counter decreased breathing in opioid overdose.<span class="mw-ref" id="cite_ref-AHFS2015_4-3"><a href="#cite_note-AHFS2015-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Naloxone may also be combined with an opioid (in the same pill), to decrease the risk of opioid misuse.<span class="mw-ref" id="cite_ref-AHFS2015_4-4"><a href="#cite_note-AHFS2015-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> When given intravenously, effects begin within two minutes,  and when injected into a muscle within five minutes.<span class="mw-ref" id="cite_ref-AHFS2015_4-5"><a href="#cite_note-AHFS2015-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Another route it can be given is by spraying it into a person's nose.<span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> The effects of naloxone last from about half an hour to an hour.<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Multiple doses may be required, as the duration of action of most opioids is greater than that of naloxone.<span class="mw-ref" id="cite_ref-AHFS2015_4-6"><a href="#cite_note-AHFS2015-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


<div role="note" class="hatnote navigation-not-searchable">Not to be confused with <a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">Naltrexone</a>.</div>

<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Naloxone</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Naloxone.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Naloxone.svg.png" data-file-width="538" data-file-height="446" data-file-type="drawing" height="187" width="225"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Naloxone-3D-balls.png" tppabs="https://ptable.com/wiki/compounds/I/m/Naloxone-3D-balls.png" data-file-width="1100" data-file-height="758" data-file-type="bitmap" height="172" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Narcan, Evzio, Nyxoid, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td><small>EN-1530; <i>N</i>-Allylnoroxymorphone; 17-Allyl-4,5α-epoxy-3,14-dihydroxymorphinan-6-one</small>, naloxone hydrochloride (USAN <small><abbr>US</abbr></small>)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/naloxone-hydrochloride.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/naloxone-hydrochloride.html'" tppabs="https://www.drugs.com/monograph/naloxone-hydrochloride.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a612022.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a612022.html'" tppabs="https://medlineplus.gov/druginfo/meds/a612022.html" class="external text external">a612022</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Naloxone  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Naloxone'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Naloxone" class="external text external">by INN</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Naloxone  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Naloxone'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Naloxone" class="external text external">Naloxone</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B1<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-0"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span><span> </span>(IV/IM/subcutaneously): B/C <span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-1"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>Endotracheal, intranasal, IV, IM, IO</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>A06AH04<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=A06AH04  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=A06AH04'" tppabs="https://www.whocc.no/atc_ddd_index/?code=A06AH04" class="external text external">WHO</a></span>)<span> </span><br>V03AB15<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=V03AB15  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=V03AB15'" tppabs="https://www.whocc.no/atc_ddd_index/?code=V03AB15" class="external text external">WHO</a></span>)</li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span>/<span>&nbsp;</span>S3 (Pharmacist Only Medicine)<span class="mw-ref" id="cite_ref-doi_10.5694/mja15.01181_2-0"><a href="#cite_note-doi_10.5694/mja15.01181-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></li>
<li><small><abbr class="country-name">DE</abbr></small>:<span> </span>§ 48 AMG/§ 1 MPAV (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span><span class="mw-ref" id="cite_ref-3"><a href="#cite_note-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span>/<span>&nbsp;</span>OTC</li>
<li>In<span>&nbsp;</span>general: ℞<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>2% (by mouth, 90% absorption but high first-pass metabolism) 50% (intranasally)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Onset of action</th><td>2 min (<abbr>IV</abbr>), 5 min (<abbr>IM</abbr>)<span class="mw-ref" id="cite_ref-AHFS2015_4-0"><a href="#cite_note-AHFS2015-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>1–1.5 h</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Duration of action</th><td>30–60 min<span class="mw-ref" id="cite_ref-AHFS2015_4-1"><a href="#cite_note-AHFS2015-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Urine, bile</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(4<i>R</i>,4a<i>S</i>,7a<i>R</i>,12b<i>S</i>)-4a,9-dihydroxy-3-(prop-2-en-1-yl)-2,3,4,4a,5,6-hexahydro-1<i>H</i>-4,12-methano[1]benzofurano[3,2-<i>e</i>]isoquinolin-7(7a<i>H</i>)-one</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=465-65-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=465-65-6'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=465-65-6" class="external text external">465-65-6</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/5284596  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/5284596'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/5284596" class="external text external">5284596</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1638  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1638'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1638" class="external text external">1638</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01183  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01183'" tppabs="https://www.drugbank.ca/drugs/DB01183" class="external text external">DB01183</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.4447644.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.4447644.html'" tppabs="http://www.chemspider.com/Chemical-Structure.4447644.html" class="external text external">4447644</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=36B82AMQ7N  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=36B82AMQ7N'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=36B82AMQ7N" class="external text external">36B82AMQ7N</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D08249  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D08249'" tppabs="https://www.kegg.jp/entry/D08249" class="external text external">D08249</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7459  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7459'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7459" class="external text external">CHEBI:7459</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL80  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL80'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL80" class="external text external">ChEMBL80</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID8023349  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID8023349'" tppabs="https://comptox.epa.gov/dashboard/DTXSID8023349" class="external text external">DTXSID8023349</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.006.697  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.006.697'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.006.697" class="external text external">100.006.697</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>19</sub><span>H</span><sub>21</sub><span>N</span><span>O</span><sub>4</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">327.380</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC1%5BC%40%40H%5D2OC3%3DC%28O%29C%3DCC4%3DC3%5BC%40%40%5D2%28%5BC%40%5D5%28CC1%29O%29CCN%28CC%3DC%29%5BC%40%40H%5D5C4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC1%5BC%40%40H%5D2OC3%3DC%28O%29C%3DCC4%3DC3%5BC%40%40%5D2%28%5BC%40%5D5%28CC1%29O%29CCN%28CC%3DC%29%5BC%40%40H%5D5C4'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC1%5BC%40%40H%5D2OC3%3DC%28O%29C%3DCC4%3DC3%5BC%40%40%5D2%28%5BC%40%5D5%28CC1%29O%29CCN%28CC%3DC%29%5BC%40%40H%5D5C4" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C1[C@@H]2OC3=C(O)C=CC4=C3[C@@]2([C@]5(CC1)O)CCN(CC=C)[C@@H]5C4</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m1/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:UZHSEJADLWPNLE-GRGSLBFTSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=440816974&page2=Naloxone  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=440816974&page2=Naloxone'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=440816974&page2=Naloxone" class="external text external">(verify)</a></span></span></td></tr></tbody></table>


<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Coma-cocktail.png" tppabs="https://ptable.com/wiki/compounds/I/m/Coma-cocktail.png" data-file-width="1080" data-file-height="1350" data-file-type="bitmap" height="275" width="220"><div class="thumbcaption" style="text-align: left">Coma-cocktail</div></div></div>
<p>Administration to opioid-dependent individuals may cause symptoms of opioid withdrawal, including restlessness, agitation, nausea, vomiting, a fast heart rate, and sweating.<span class="mw-ref" id="cite_ref-AHFS2015_4-7"><a href="#cite_note-AHFS2015-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> To prevent this, small doses every few minutes can be given until the desired effect is reached.<span class="mw-ref" id="cite_ref-AHFS2015_4-8"><a href="#cite_note-AHFS2015-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> In those with previous heart disease or taking medications that negatively affect the heart, further heart problems have occurred.<span class="mw-ref" id="cite_ref-AHFS2015_4-9"><a href="#cite_note-AHFS2015-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It appears to be safe in pregnancy, after having been given to a limited number of women.<span class="mw-ref" id="cite_ref-TGA2014_7-0"><a href="#cite_note-TGA2014-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Naloxone is a non-selective and competitive opioid receptor antagonist.<span class="mw-ref" id="cite_ref-NHM-Naloxone_pharmacology_8-0"><a href="#cite_note-NHM-Naloxone_pharmacology-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-Narcan_Prescribing_Information_9-0"><a href="#cite_note-Narcan_Prescribing_Information-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> It works by reversing the depression of the central nervous system and respiratory system caused by opioids.<span class="mw-ref" id="cite_ref-AHFS2015_4-10"><a href="#cite_note-AHFS2015-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


<p>Naloxone was patented in 1961 and approved for opioid overdose in the United States in 1971.<span class="mw-ref" id="cite_ref-nyti_Jack_10-0"><a href="#cite_note-nyti_Jack-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> It is on the World Health Organization's List of Essential Medicines.<span class="mw-ref" id="cite_ref-WHO21st_12-0"><a href="#cite_note-WHO21st-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Naloxone is available as a generic medication.<span class="mw-ref" id="cite_ref-AHFS2015_4-11"><a href="#cite_note-AHFS2015-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>  
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Opioid_overdose">Opioid overdose</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/NaloxoneKit.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/NaloxoneKit.jpg" data-file-width="3964" data-file-height="3270" data-file-type="bitmap" height="181" width="220"><div class="thumbcaption" style="text-align: left">A naloxone kit as distributed in British Columbia, Canada</div></div></div>
<p>Naloxone is useful in treating both acute opioid overdose and respiratory or mental depression due to opioids.<span class="mw-ref" id="cite_ref-AHFS2015_4-12"><a href="#cite_note-AHFS2015-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Whether it is useful in those in cardiac arrest due to an opioid overdose is unclear.<span class="mw-ref" id="cite_ref-special_circum_2015_13-0"><a href="#cite_note-special_circum_2015-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<p>It is included as a part of emergency overdose response kits distributed to <a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">heroin</a> and other opioid drug users and emergency responders. This has been shown to reduce rates of deaths due to overdose.<span class="mw-ref" id="cite_ref-pmid16956873_14-0"><a href="#cite_note-pmid16956873-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> A prescription for naloxone is recommended if a person is on a high dose of opioid (&gt;100<span>&nbsp;</span>mg of morphine equivalence/day), is prescribed any dose of opioid accompanied by a benzodiazepine, or is suspected or known to use opioids nonmedically.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Prescribing naloxone should be accompanied by standard education that includes preventing, identifying, and responding to an overdose; rescue breathing; and calling emergency services.<span class="mw-ref" id="cite_ref-pmid23664112_16-0"><a href="#cite_note-pmid23664112-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>

<p>If minimal or no response is observed within 2–3 minutes, dosing may be repeated every 2 minutes until the maximum dose of 10<span>&nbsp;</span>mg has been reached. If no response occurs at this time, alternative diagnosis and treatment should be pursued. Depending on the severity of overdose, a high dose exceeding 10<span>&nbsp;</span>mg may be needed.<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> The effects of naloxone may wear off before those of the opioids, and they may require repeat dosing at a later time. Patients experiencing effects should be monitored for respiratory rate, heart rate, blood pressure, temperature, ABGs and level of consciousness. Those with a greater risk for respiratory depression should be identified prior to administration and watched closely.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Clonidine_overdose">Clonidine overdose</h3></summary>
    

<p>Naloxone can also be used as an antidote in overdose of <a href="Clonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clonidine" title="Clonidine">clonidine</a>, a medication that lowers blood pressure.<span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> Clonidine overdoses are of special relevance for children, in whom even small doses can cause significant harm.<span class="mw-ref" id="cite_ref-Ahmad_et_al_2015_Review_20-0"><a href="#cite_note-Ahmad_et_al_2015_Review-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> However, there is controversy regarding naloxone's efficacy in treating the symptoms of clonidine overdose, namely slow heart rate, low blood pressure, and confusion/somnolence.<span class="mw-ref" id="cite_ref-Ahmad_et_al_2015_Review_20-1"><a href="#cite_note-Ahmad_et_al_2015_Review-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> Case reports that used doses of 0.1<span>&nbsp;</span>mg/kg (maximum of 2<span>&nbsp;</span>mg/dose) repeated every 1–2 minutes (10<span>&nbsp;</span>mg total dose) have shown inconsistent benefit.<span class="mw-ref" id="cite_ref-Ahmad_et_al_2015_Review_20-2"><a href="#cite_note-Ahmad_et_al_2015_Review-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> As the doses used throughout the literature vary, it is difficult to form a conclusion regarding the benefit of naloxone in this setting.<span class="mw-ref" id="cite_ref-Seger_DL_Review_21-0"><a href="#cite_note-Seger_DL_Review-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> The mechanism for naloxone's proposed benefit in clonidine overdose is unclear, but it has been suggested that endogenous opioid receptors mediate the sympathetic nervous system in the brain and elsewhere in the body.<span class="mw-ref" id="cite_ref-Seger_DL_Review_21-1"><a href="#cite_note-Seger_DL_Review-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> Some poison control centers recommend naloxone in the setting of clonidine overdose, including intravenous bolus doses of up to 10<span>&nbsp;</span>mg naloxone.<span class="mw-ref" id="cite_ref-Missouri_Poison_Control_22-0"><a href="#cite_note-Missouri_Poison_Control-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-Tennessee_Poison_Center_23-0"><a href="#cite_note-Tennessee_Poison_Center-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Preventing_opioid_abuse">Preventing opioid abuse</h3></summary>
    
<p>Naloxone is poorly absorbed when taken by mouth, so it is commonly combined with a number of oral opioid preparations, including <a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">buprenorphine</a> and <a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">pentazocine</a>, so that when taken by mouth, only the opioid has an effect.<span class="mw-ref" id="cite_ref-AHFS2015_4-13"><a href="#cite_note-AHFS2015-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Orman2009_24-0"><a href="#cite_note-Orman2009-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> However, if the opioid and naloxone combination is injected, the naloxone blocks the effect of the opioid.<span class="mw-ref" id="cite_ref-AHFS2015_4-14"><a href="#cite_note-AHFS2015-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Orman2009_24-1"><a href="#cite_note-Orman2009-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> This combination is used in an effort to prevent abuse.<span class="mw-ref" id="cite_ref-Orman2009_24-2"><a href="#cite_note-Orman2009-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Other_uses">Other uses</h3></summary>
    
<p>In people with shock, including septic, cardiogenic, hemorrhagic, or spinal shock, those who received naloxone had improved blood flow. The importance of this is unclear.<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>

<p>Naloxone is also experimentally used in the treatment for congenital insensitivity to pain with anhidrosis,<span class="mw-ref" id="cite_ref-Protheroe's_Review_26-0"><a href="#cite_note-Protheroe's_Review-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> an extremely rare disorder that renders one unable to feel pain or differentiate temperatures.<span class="mw-ref" id="cite_ref-CIPA_Genetics_Home_27-0"><a href="#cite_note-CIPA_Genetics_Home-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>

<p>Naloxone can also be used to treat itchiness brought on by opioid use,<span class="mw-ref" id="cite_ref-:1_28-0"><a href="#cite_note-:1-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> as well as opioid-induced constipation.<span class="mw-ref" id="cite_ref-pmid10601678_29-0"><a href="#cite_note-pmid10601678-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Special_populations">Special populations</h3></summary>
    

</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Pregnancy_and_breastfeeding">Pregnancy and breastfeeding</h4></summary>
    
<p>Naloxone is pregnancy category B or C in the United States.<span class="mw-ref" id="cite_ref-AHFS2015_4-15"><a href="#cite_note-AHFS2015-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Studies in rodents given a daily maximum dose of 10<span>&nbsp;</span>mg naloxone showed no harmful effects to the fetus, although human studies are lacking and the drug does cross the placenta, which may lead to the precipitation of withdrawal in the fetus. In this setting, further research is needed before safety can be assured, so naloxone should be used during pregnancy only if it is a medical necessity.<span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>

<p>Whether naloxone is excreted in breast milk is unknown, however, it is not orally bioavailable and therefore is unlikely to affect a breastfeeding infant.<span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Children">Children</h4></summary>
    
<p>Naloxone can be used on infants who were exposed to intrauterine opiates administered to mothers during delivery. However, there is insufficient evidence for the use of naloxone to lower cardiorespiratory and neurological depression in these infants.<span class="mw-ref" id="cite_ref-32"><a href="#cite_note-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> Infants exposed to high concentrations of opiates during pregnancy may have CNS damage in the setting of perinatal asphyxia. Naloxone has been studied to improve outcomes in this population, however the evidence is currently weak.<span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-34"><a href="#cite_note-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span></p>

<p>Intravenous, intramuscular, or subcutaneous administration of naloxone can be given to children and neonates to reverse opiate effects. The American Academy of Pediatrics recommends only intravenous administration as the other two forms can cause unpredictable absorption. After a dose is given, the child should be monitored for at least 24 hours. For children with low blood pressure due to septic shock, naloxone safety and effectiveness is not established.<span class="mw-ref" id="cite_ref-35"><a href="#cite_note-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Geriatric_use">Geriatric use</h4></summary>
    
<p>For patients 65 years and older, unclear if there is a difference in response. However, older people often have decreased liver and kidney function that may lead to an increased level of naloxone in their body.<span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>Naloxone has little to no effect if opioids are not present. In people with opioids in their system, it may cause increased sweating, nausea, restlessness, trembling, vomiting, flushing, and headache, and has in rare cases been associated with heart rhythm changes, seizures, and pulmonary edema.<span class="mw-ref" id="cite_ref-37"><a href="#cite_note-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span><span class="mw-ref" id="cite_ref-pmid3662194_38-0"><a href="#cite_note-pmid3662194-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span></p>

<p>Besides the side effects listed above, naloxone also has other adverse events, such as other cardiovascular effects (hypertension, hypotension, tachycardia, ventricular fibrillation, ventricular tachycardia) and central nervous system effects, such as agitation, body pain, brain disease, and coma. In addition to these adverse effects, naloxone is also contraindicated in people with hypersensitivity to naloxone or any of its formulation components.<span class="mw-ref" id="cite_ref-39"><a href="#cite_note-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span></p>

<p>Naloxone has been shown to block the action of pain-lowering endorphins the body produces naturally. These endorphins likely operate on the same opioid receptors that naloxone blocks. It is capable of blocking a placebo pain-lowering response, if the placebo is administered together with a hidden or blind injection of naloxone.<span class="mw-ref" id="cite_ref-pmid15820838_40-0"><a href="#cite_note-pmid15820838-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span> Other studies have found that placebo alone can activate the body's μ-opioid endorphin system, delivering pain relief by the same receptor mechanism as morphine.<span class="mw-ref" id="cite_ref-41"><a href="#cite_note-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span><span class="mw-ref" id="cite_ref-42"><a href="#cite_note-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></p>

<p>Naloxone should be used with caution in people with cardiovascular disease as well as those that are currently taking medications that could have adverse effects on the cardiovascular system such as causing low blood pressure, fluid accumulation in the lungs (pulmonary edema), and abnormal heart rhythms. There have been reports of abrupt reversals with opioid antagonists leading to pulmonary edema and ventricular fibrillation.<span class="mw-ref" id="cite_ref-43"><a href="#cite_note-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span></p>


    <details data-level="4" open="">
    <summary class="section-heading"><h4 id="Hypersensitivities">Hypersensitivities</h4></summary>
    
<p>Naloxone preparations may contain methylparaben and propylparaben and is inappropriate for use by people with a paraben hypersensitivity. If a person is sensitive to <a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">nalmefene</a> or <a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">naltrexone</a>, naloxone should be used with caution as these three medications are structurally similar. Cross-sensitivity among these drugs is unknown.<span class="mw-ref" id="cite_ref-:3_44-0"><a href="#cite_note-:3-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> Preservative-free preparations are available for those with paraben hypersensitivities.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    
<table class="wikitable floatright" style="text-align: center;">
<caption>Naloxone at opioid receptors</caption>
<tbody><tr>
<th rowspan="2">Compound</th><th colspan="3">Affinities (<abbr>K<sub>i</sub></abbr>)</th><th>Ratio</th><th rowspan="2">Ref</th></tr>
<tr>
<th><abbr>MOR</abbr></th><th><abbr>DOR</abbr></th><th><abbr>KOR</abbr></th><th>MOR:DOR:KOR</th></tr>
<tr>
<td>Naloxone</td><td>1.1 nM</td><td>16 nM</td><td>12 nM</td><td>1:15:11</td><td><span class="mw-ref" id="cite_ref-pmid2986989_45-0"><a href="#cite_note-pmid2986989-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span></td></tr>
<tr>
<td>(−)-Naloxone</td><td>0.559 nM<br>0.93 nM</td><td>36.5 nM<br>17 nM</td><td>4.91 nM<br>2.3 nM</td><td>1:65:9<br>1:18:2</td><td><span class="mw-ref" id="cite_ref-pmid7562497_46-0"><a href="#cite_note-pmid7562497-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><br><span class="mw-ref" id="cite_ref-pmid8114680_47-0"><a href="#cite_note-pmid8114680-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span></td></tr>
<tr>
<td>(+)-Naloxone</td><td>3,550 nM<br>1,000 nM</td><td>122,000 nM<br>1,000 nM</td><td>8,950 nM<br>1,000 nM</td><td>1:34:3<br><abbr>ND</abbr></td><td><span class="mw-ref" id="cite_ref-pmid7562497_46-1"><a href="#cite_note-pmid7562497-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><br><span class="mw-ref" id="cite_ref-pmid8114680_47-1"><a href="#cite_note-pmid8114680-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span></td></tr>
</tbody></table>

<p>Naloxone is a lipophilic compound that acts as a non-selective and competitive opioid receptor antagonist.<span class="mw-ref" id="cite_ref-NHM-Naloxone_pharmacology_8-1"><a href="#cite_note-NHM-Naloxone_pharmacology-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-Narcan_Prescribing_Information_9-1"><a href="#cite_note-Narcan_Prescribing_Information-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> The pharmacologically active isomer of naloxone is (−)-naloxone.<span class="mw-ref" id="cite_ref-pmid7562497_46-2"><a href="#cite_note-pmid7562497-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><span class="mw-ref" id="cite_ref-Naloxone_IUPHAR_48-0"><a href="#cite_note-Naloxone_IUPHAR-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> Naloxone's binding affinity is highest for the μ-opioid receptor, then the δ-opioid receptor, and lowest for the κ-opioid receptor;<span class="mw-ref" id="cite_ref-NHM-Naloxone_pharmacology_8-2"><a href="#cite_note-NHM-Naloxone_pharmacology-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> naloxone has negligible affinity for the nociceptin receptor.<span class="mw-ref" id="cite_ref-Opioid_receptor_family_–_IUPHAR_49-0"><a href="#cite_note-Opioid_receptor_family_–_IUPHAR-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span></p>

<p>If naloxone is administered in the absence of concomitant opioid use, no functional pharmacological activity occurs, except the inability for the body to combat pain naturally. In contrast to direct opiate agonists, which elicit opiate withdrawal symptoms when discontinued in opiate-tolerant people, no evidence indicates the development of tolerance or dependence on naloxone. The mechanism of action is not completely understood, but studies suggest it functions to produce withdrawal symptoms by competing for opiate receptor sites within the CNS (a competitive antagonist, not a direct agonist), thereby preventing the action of both endogenous and xenobiotic opiates on these receptors without directly producing any effects itself.<span class="mw-ref" id="cite_ref-Daily_Med_50-0"><a href="#cite_note-Daily_Med-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>When administered <a href="javascript:if(confirm('https://en.wiktionary.org/wiki/parenteral  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wiktionary.org/wiki/parenteral'" tppabs="https://en.wiktionary.org/wiki/parenteral" title="wikt:parenteral" class="external">parenterally</a> (nonorally or nonrectally, e.g. intravenously or by injection), as is most common, naloxone has a rapid distribution throughout the body. The mean serum half life has been shown to range from 30 to 81 minutes, shorter than the average half life of some opiates, necessitating repeat dosing if opioid receptors must be stopped from triggering for an extended period. Naloxone is primarily metabolized by the liver. Its major metabolite is naloxone-3-glucuronide, which is excreted in the urine.<span class="mw-ref" id="cite_ref-Daily_Med_50-1"><a href="#cite_note-Daily_Med-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span> For people with liver diseases such as alcoholic liver disease or hepatitis, naloxone usage has not been shown to increase serum liver enzyme levels.<span class="mw-ref" id="cite_ref-51"><a href="#cite_note-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span></p>

<p>Naloxone has low systemic bioavailability when taken by mouth due to hepatic first pass metabolism, but it does block opioid receptors that are located in the intestine.<span class="mw-ref" id="cite_ref-pmid10601678_29-1"><a href="#cite_note-pmid10601678-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<p>Naloxone, also known as N-allylnoroxymorphone or as 17-allyl-4,5α-epoxy-3,14-dihydroxymorphinan-6-one, is a synthetic morphinan derivative and was derived from <a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">oxymorphone</a> (14-hydroxydihydromorphinone), an opioid analgesic.<span class="mw-ref" id="cite_ref-DeanBilsky2009_52-0"><a href="#cite_note-DeanBilsky2009-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span><span class="mw-ref" id="cite_ref-Nagase2011_53-0"><a href="#cite_note-Nagase2011-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span><span class="mw-ref" id="cite_ref-NIST_54-0"><a href="#cite_note-NIST-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span> Oxymorphone, in turn, was derived from <a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">morphine</a>, an opioid analgesic and naturally occurring constituent of the opium poppy.<span class="mw-ref" id="cite_ref-SeppalaRose2011_55-0"><a href="#cite_note-SeppalaRose2011-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> Naloxone is a racemic mixture of two enantiomers, (–)-naloxone (levonaloxone) and (+)-naloxone (dextronaloxone), only the former of which is active at opioid receptors.<span class="mw-ref" id="cite_ref-Bennett2006_56-0"><a href="#cite_note-Bennett2006-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span><span class="mw-ref" id="cite_ref-Wang2003_57-0"><a href="#cite_note-Wang2003-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span> The drug is a highly lipophilic, allowing it to rapidly penetrate the brain and to achieve a far greater brain to serum ratio than that of morphine.<span class="mw-ref" id="cite_ref-DeanBilsky2009_52-1"><a href="#cite_note-DeanBilsky2009-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> Opioid antagonists related to naloxone include cyprodime, <a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">nalmefene</a>, nalodeine, naloxol, and <a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">naltrexone</a>.<span class="mw-ref" id="cite_ref-BruntonChabner2010_58-0"><a href="#cite_note-BruntonChabner2010-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span></p>

<p>The chemical half-life of naloxone is such that injection and nasal forms have been marketed with 24-month and 18-month shelf-lives, respectively.<span class="mw-ref" id="cite_ref-:2_59-0"><a href="#cite_note-:2-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span>  A 2018 study noted that the nasal and injection forms presented as chemically stable to 36- and 28-months, respectively, which prompted an as yet incomplete five year stability study to be initiated.<span class="mw-ref" id="cite_ref-:2_59-1"><a href="#cite_note-:2-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span>  This suggests that expired caches of material in community and healthcare settings may still be efficacious substantially beyond their labeled expiration dates.<span class="mw-ref" id="cite_ref-:2_59-2"><a href="#cite_note-:2-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Naloxone was patented in 1961 by Mozes J. Lewenstein, Jack Fishman, and the company Sankyo.<span class="mw-ref" id="cite_ref-nyti_Jack_10-1"><a href="#cite_note-nyti_Jack-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> It was approved for opioid abuse treatment in the United States in 1971,<span class="mw-ref" id="cite_ref-60"><a href="#cite_note-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span> with opioid abuse kits being distributed by many states to medically untrained people beginning in 1996. From the period of 1996 to 2014, the CDC estimates over 26,000 cases of opioid overdose have been reversed using the kits.<span class="mw-ref" id="cite_ref-61"><a href="#cite_note-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span></p>

<p>Naloxone (Nyxoid) was approved for use in the European Union in September 2017.<span class="mw-ref" id="cite_ref-Nyxoid_EPAR_62-0"><a href="#cite_note-Nyxoid_EPAR-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Names">Names</h3></summary>
    
<p><i>Naloxone</i> is the generic name of the medication and its <abbr>INN</abbr>, <abbr>BAN</abbr>, <abbr>DCF</abbr>, <abbr>DCIT</abbr>, and <abbr>JAN</abbr>, while <i>naloxone hydrochloride</i> is its <abbr>USAN</abbr> and <abbr>BANM</abbr>.<span class="mw-ref" id="cite_ref-Elks2014_63-0"><a href="#cite_note-Elks2014-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_64-0"><a href="#cite_note-IndexNominum2000-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span><span class="mw-ref" id="cite_ref-MortonHall2012_65-0"><a href="#cite_note-MortonHall2012-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_66-0"><a href="#cite_note-Drugs.com-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span></p>

<p>The patent has expired and it is available as a generic medication. Brand names of naloxone include Narcan, Nalone, Evzio, Prenoxad Injection, Narcanti, Narcotan, among others.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Identification">Identification</h3></summary>
    
<p>The CAS number of naloxone is 465-65-6; the anhydrous hydrochloride salt has CAS 357-08-4 and the hydrochloride salt with 2 molecules of water, hydrochloride dihydrate, has CAS 51481-60-8</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Routes_of_administration">Routes of administration</h3></summary>
    


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Intravenous">Intravenous</h4></summary>
    
<p>Naloxone is commonly injected intravenously, with an onset of 1–2 minutes and a duration of up to 45 minutes.<span class="mw-ref" id="cite_ref-Lexicomp._2013_67-0"><a href="#cite_note-Lexicomp._2013-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span> While the onset is achieved fastest through IV than through other routes of administration, it may be difficult to obtain venous access in patients who use IV drugs chronically. This may be an issue under emergency conditions.<span class="mw-ref" id="cite_ref-68"><a href="#cite_note-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Intramuscular_or_subcutaneous">Intramuscular or subcutaneous</h4></summary>
    
<p>Naloxone can also be administered via intramuscular or subcutaneous injection. The onset of naloxone provided through this route is 2 to 5 minutes with a duration of around 30-120min.<span class="mw-ref" id="cite_ref-:0_69-0"><a href="#cite_note-:0-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> Naloxone administered intramuscularly are provided through pre-filled syringes, vials, and auto-injector. Evzio is the only auto-injector on the market and can be used both intramuscularly and subcutaneously. It is pocket-sized and can be used in non-medical settings such as in the home.<span class="mw-ref" id="cite_ref-special_circum_2015_13-1"><a href="#cite_note-special_circum_2015-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> It is designed for use by laypersons, including family members and caregivers of opioid users at-risk for an opioid emergency, such as an overdose.<span class="mw-ref" id="cite_ref-FDA_News_Release_70-0"><a href="#cite_note-FDA_News_Release-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span> According to the FDA's National Drug Code Directory, a generic version of the auto-injector began to be marketed at the end of 2019.<span class="mw-ref" id="cite_ref-:5_71-0"><a href="#cite_note-:5-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Intranasal">Intranasal</h4></summary>
    
<p>Administration of naloxone intranasally is recommended for people who are unconscious or unresponsive.<span class="mw-ref" id="cite_ref-:0_69-1"><a href="#cite_note-:0-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> While the onset of action is slightly delayed in this method of administration, the ease of use and portability are what make naloxone nasal sprays useful.<span class="mw-ref" id="cite_ref-Lexicomp._2013_67-1"><a href="#cite_note-Lexicomp._2013-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span><span class="mw-ref" id="cite_ref-:0_69-2"><a href="#cite_note-:0-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> Narcan Nasal Spray was approved in 2015 and was the first FDA-approved nasal spray for emergency treatment or suspected overdose.<span class="mw-ref" id="cite_ref-72"><a href="#cite_note-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span> Narcan Nasal Spray is prepackaged, requires no assembly, and delivered a consistent dose.<span class="mw-ref" id="cite_ref-73"><a href="#cite_note-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span> It was developed in a partnership between LightLake Therapeutics and the National Institute on Drug Abuse.<span class="mw-ref" id="cite_ref-74"><a href="#cite_note-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span> The approval process was fast-tracked.<span class="mw-ref" id="cite_ref-75"><a href="#cite_note-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span> A generic version of the nasal spray was approved in the United States in 2019.<span class="mw-ref" id="cite_ref-76"><a href="#cite_note-76" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span></p>

<p>However, a wedge device (nasal atomizer) can also be attached to a syringe that may also be used to create a mist to deliver the drug to the nasal<span>&nbsp;</span>mucosa.<span class="mw-ref" id="cite_ref-pmid15039670_77-0"><a href="#cite_note-pmid15039670-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span> This is useful near facilities where many overdoses occur that already stock injectors.<span class="mw-ref" id="cite_ref-78"><a href="#cite_note-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Storage">Storage</h3></summary>
    
<p>Naloxone should be stored at room temperature and protected from light. For the auto-injector, naloxone should be stored in the outer case provided.<span class="mw-ref" id="cite_ref-79"><a href="#cite_note-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span> If the product is cloudy, discolored, or contains particulate matter, use is not recommended.<span class="mw-ref" id="cite_ref-:3_44-1"><a href="#cite_note-:3-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Labeling">Labeling</h3></summary>
    
<p>The opioid crisis in the US points out the necessity for an increase in the availability of the opioid antagonist naloxone as administered in overdose situations. In May 2020, the FDA reported on its creation of a “model drug facts label” that would enable average consumers with little or no specific training to comprehend the major components in effective, safe administration of naloxone. The agency used two prescription products in its test: the prefilled auto-injector Evzio and the nasal spray Narcan, both approved for community use in 2016. Working with experts on addiction, FDA researchers condensed the clinical information on naloxone (6,300 words over 18 pages) to eight “primary end points” providing essential data on usage in a crisis overdose emergency. The trial consisted of interviews with 710 adolescents and adults, including 430 opioid users, along with their family and friends. Results indicated that those being interviewed sufficiently understood six of the eight primary end points, and “came close” on the remaining two. The agency concluded the model label was adequate for use on naloxone sold over the counter. FDA also reported that if individuals comprehend instructions, administer naloxone and call 911, “…many lives will be saved.” They also recommended that manufacturers highlight “Call 911” on package labels.<span class="mw-ref" id="cite_ref-CohenMahoney2020_80-0"><a href="#cite_note-CohenMahoney2020-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Legal_status">Legal status</h3></summary>
    
<p>In the United States, naloxone is available without a prescription in every state with the exception of Hawaii.<span class="mw-ref" id="cite_ref-81"><a href="#cite_note-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span><span class="mw-ref" id="cite_ref-82"><a href="#cite_note-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span> However, not all pharmacies stock or dispense naloxone.<span class="mw-ref" id="cite_ref-83"><a href="#cite_note-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span><span class="mw-ref" id="cite_ref-84"><a href="#cite_note-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span> Depending on the pharmacy, a pharmacist may have to write a prescription or not be able to give naloxone to comply with accounting rules regarding prescription medications, as naloxone is still considered a prescription only medication under FDA rules.</p>

<p>While paramedics have carried naloxone for decades, law enforcement officers in many states throughout the country carry naloxone to reverse the effects of heroin overdoses when reaching the location prior to paramedics. As of July 12, 2015, law enforcement departments in 28 states are allowed to or required to carry naloxone to quickly respond to opioid overdoses.<span class="mw-ref" id="cite_ref-85"><a href="#cite_note-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span></p>

<p>In Australia, as of February 1, 2016, some forms of naloxone are available "over the counter" in pharmacies without a prescription.<span class="mw-ref" id="cite_ref-doi_10.5694/mja15.01181_2-1"><a href="#cite_note-doi_10.5694/mja15.01181-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-86"><a href="#cite_note-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span><span class="mw-ref" id="cite_ref-87"><a href="#cite_note-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span> It comes in single-use filled syringe similar to law enforcement kits. A single dose costs AU$20; for those with a prescription, five doses can bought for AU$40, amounting to a rate of eight dollars per dose (2019).<span class="mw-ref" id="cite_ref-88"><a href="#cite_note-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span></p>

<p>In Canada, naloxone single-use syringe kits are distributed and available at various clinics and emergency rooms. Alberta Health Services is increasing the distribution points for naloxone kits at all emergency rooms, and various pharmacies and clinics province-wide. Also in Alberta, take-home naloxone kits are available and commonly distributed in most drug treatment or rehabilitation centres, as well as in pharmacies where pharmacists can distribute single-use take-home naloxone kits or prescribe the drug to addicts. All Edmonton Police Service and Calgary Police Service patrol cars carry an emergency single-use naloxone syringe kit. Some Royal Canadian Mounted Police patrol vehicles also carry the drug, occasionally in excess to help distribute naloxone among users and concerned family/friends. Nurses, paramedics, medical technicians, and emergency medical responders can also prescribe and distribute the drug.</p>

<p>Following Alberta Health Services, Health Canada reviewed the prescription-only status of naloxone, resulting in plans to remove it in 2016, allowing naloxone to be more accessible.<span class="mw-ref" id="cite_ref-89"><a href="#cite_note-89" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span><span class="mw-ref" id="cite_ref-90"><a href="#cite_note-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span> Due to the rising number of drug deaths across the country, Health Canada proposed a change to make naloxone more widely available to Canadians in support of efforts to address the growing number of opioid overdoses.<span class="mw-ref" id="cite_ref-91"><a href="#cite_note-91" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span> In March 2016, Health Canada did change the prescription status of naloxone, as "pharmacies are now able to proactively give out naloxone to those who might experience or witness an opioid overdose."<span class="mw-ref" id="cite_ref-92"><a href="#cite_note-92" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Prehospital_access">Prehospital access</h3></summary>
    
<p>Laws in many jurisdictions have been changed in recent years to allow wider distribution of naloxone.<span class="mw-ref" id="cite_ref-93"><a href="#cite_note-93" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span><span class="mw-ref" id="cite_ref-94"><a href="#cite_note-94" style="counter-reset: mw-Ref 94;"><span class="mw-reflink-text">[94]</span></a></span> Several states have also moved to permit pharmacies to dispense the medication without the person first seeing a physician or other non-pharmacist professional.<span class="mw-ref" id="cite_ref-95"><a href="#cite_note-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span> Over 200 naloxone distribution programs utilize licensed prescribers to distribute the drug, often through the use of standing medication orders <span class="mw-ref" id="cite_ref-Beletsky_2009_96-0"><a href="#cite_note-Beletsky_2009-96" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span><span class="mw-ref" id="cite_ref-97"><a href="#cite_note-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span> whereby the medication is distributed under the medical authority of a physician or other prescriber (such as a pharmacist under California's AB1535).  Additionally, 36 states have passed laws that provide naloxone prescribers with immunity against both civil and criminal liabilities.<span class="mw-ref" id="cite_ref-:4_98-0"><a href="#cite_note-:4-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span> Third-party prescriptions are also available for people, such as family and friends of people at risk for an overdose, who may find themselves in a situation that requires them to administer naloxone. Local schools, government agencies, and nonprofit organizations hold training programs to educate laypeople on proper use of naloxone. It is estimated that programs like these have helped to reverse more than 26,000 overdoses.<span class="mw-ref" id="cite_ref-:4_98-1"><a href="#cite_note-:4-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span></p>

<p>Following the use of the nasal spray device by police officers on Staten Island in New York, an additional 20,000 police officers will begin carrying naloxone in mid-2014. The state's Office of the Attorney General will provide US$1.2 million to supply nearly 20,000 kits. Police Commissioner William Bratton said: "Naloxone gives individuals a second chance to get help".<span class="mw-ref" id="cite_ref-99"><a href="#cite_note-99" style="counter-reset: mw-Ref 99;"><span class="mw-reflink-text">[99]</span></a></span> Emergency Medical Service Providers (EMS) routinely administer naloxone, except where basic Emergency Medical Technicians are prohibited by policy or by state law.<span class="mw-ref" id="cite_ref-100"><a href="#cite_note-100" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span> In efforts to encourage citizens to seek help for possible opioid overdoses, many states have adopted Good Samaritan laws that provide immunity against certain criminal liabilities for anybody who, in good faith, seeks emergency medical care for either themselves or someone around them who may be experiencing an opioid overdose.<span class="mw-ref" id="cite_ref-101"><a href="#cite_note-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span></p>

<p>A survey of US naloxone prescription programs in 2010 revealed that 21 out of 48 programs reported challenges in obtaining naloxone in the months leading up to the survey, due mainly to either cost increases that outstripped allocated funding or the suppliers' inability to fill orders.<span class="mw-ref" id="cite_ref-cdc.gov_102-0"><a href="#cite_note-cdc.gov-102" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span> The approximate cost of a 1<span>&nbsp;</span>ml ampoule of naloxone in the US is estimated to be significantly higher than in most Western countries.<span class="mw-ref" id="cite_ref-Beletsky_2009_96-1"><a href="#cite_note-Beletsky_2009-96" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span></p>

<p>Projects of this type are under way in many North American cities.<span class="mw-ref" id="cite_ref-cdc.gov_102-1"><a href="#cite_note-cdc.gov-102" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span><span class="mw-ref" id="cite_ref-103"><a href="#cite_note-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span> CDC estimates that the US programs for drug users and their caregivers prescribing take-home doses of naloxone and training on its use have prevented 10,000 opioid overdose deaths.<span class="mw-ref" id="cite_ref-cdc.gov_102-2"><a href="#cite_note-cdc.gov-102" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span> States including Vermont and Virginia have developed programs that mandate the prescription of naloxone when a prescription has exceeded a certain level of morphine milliequivalents per day as preventative measures against overdose.<span class="mw-ref" id="cite_ref-104"><a href="#cite_note-104" style="counter-reset: mw-Ref 104;"><span class="mw-reflink-text">[104]</span></a></span> Healthcare institution-based naloxone prescription programs have also helped reduce rates of opioid overdose in North Carolina, and have been replicated in the US military.<span class="mw-ref" id="cite_ref-Beletsky_2009_96-2"><a href="#cite_note-Beletsky_2009-96" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span><span class="mw-ref" id="cite_ref-pmid21668761_105-0"><a href="#cite_note-pmid21668761-105" style="counter-reset: mw-Ref 105;"><span class="mw-reflink-text">[105]</span></a></span> Programs training police and fire personnel in opioid overdose response using naloxone have also shown promise in the US, and effort is increasing to integrate opioid fatality prevention in the overall response to the overdose crisis.<span class="mw-ref" id="cite_ref-Beletsky_2012_106-0"><a href="#cite_note-Beletsky_2012-106" style="counter-reset: mw-Ref 106;"><span class="mw-reflink-text">[106]</span></a></span><span class="mw-ref" id="cite_ref-107"><a href="#cite_note-107" style="counter-reset: mw-Ref 107;"><span class="mw-reflink-text">[107]</span></a></span><span class="mw-ref" id="cite_ref-pmid19602236_108-0"><a href="#cite_note-pmid19602236-108" style="counter-reset: mw-Ref 108;"><span class="mw-reflink-text">[108]</span></a></span><span class="mw-ref" id="cite_ref-109"><a href="#cite_note-109" style="counter-reset: mw-Ref 109;"><span class="mw-reflink-text">[109]</span></a></span></p>

<p>Pilot projects were also started in Scotland in 2006. Also in the UK, in December 2008, the Welsh Assembly government announced its intention to establish demonstration sites for take-home naloxone.<span class="mw-ref" id="cite_ref-110"><a href="#cite_note-110" style="counter-reset: mw-Ref 110;"><span class="mw-reflink-text">[110]</span></a></span></p>

<p>As of February 2016, Pharmacies across Alberta and some other Canadian jurisdictions are allowed to distribute take-home naloxone kits. Additionally, the Minister of Health issued an order to change basic life support provider's medical scope, within EMS, to administer naloxone in the event of a suspected narcotic overdose. These are part of the government's plan to tackle a growing <a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">fentanyl</a> drug crisis.<span class="mw-ref" id="cite_ref-cbc.ca_111-0"><a href="#cite_note-cbc.ca-111" style="counter-reset: mw-Ref 111;"><span class="mw-reflink-text">[111]</span></a></span></p>

<p>In 2018, a maker of naloxone announced it would  provide a free kit including two doses of the nasal spray, as well as educational materials, to each of the 16,568 public libraries and 2,700 YMCAs in the U.S.<span class="mw-ref" id="cite_ref-112"><a href="#cite_note-112" style="counter-reset: mw-Ref 112;"><span class="mw-reflink-text">[112]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Media">Media</h3></summary>
    
<p>The 2013 documentary film <i>Reach for Me: Fighting to End the American Drug Overdose Epidemic</i> interviews people involved in naloxone programs aiming to make naloxone available to opioid users and people with chronic pain.<span class="mw-ref" id="cite_ref-113"><a href="#cite_note-113" style="counter-reset: mw-Ref 113;"><span class="mw-reflink-text">[113]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Buprenorphine/naloxone</li>
<li>Oxycodone/naloxone</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Drugs.com_pregnancy-1"> <span id="mw-reference-text-cite_note-Drugs.com_pregnancy-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pregnancy/naloxone.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy/naloxone.html'" tppabs="https://www.drugs.com/pregnancy/naloxone.html" class="external text external">"Naloxone Use During Pregnancy"</a>. <i>Drugs.com</i>. 2 September 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">13 May</span> 2020</span>.</cite></span></li><li id="cite_note-doi_10.5694/mja15.01181-2"> <span id="mw-reference-text-cite_note-doi_10.5694/mja15.01181-2" class="mw-reference-text"><cite id="CITEREFLentonDietzeJauncey2016" class="citation journal cs1">Lenton, Simon R; Dietze, Paul M; Jauncey, Marianne (7 March 2016). <a href="javascript:if(confirm('https://www.mja.com.au/journal/2016/204/4/australia-reschedules-naloxone-opioid-overdose  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.mja.com.au/journal/2016/204/4/australia-reschedules-naloxone-opioid-overdose'" tppabs="https://www.mja.com.au/journal/2016/204/4/australia-reschedules-naloxone-opioid-overdose" class="external text external">"Australia reschedules naloxone for opioid overdose"</a>. <i>The Medical Journal of Australia</i>. <b>204</b> (4): 146–147. doi:<a href="javascript:if(confirm('https://doi.org/10.5694%2Fmja15.01181  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5694%2Fmja15.01181'" tppabs="https://doi.org/10.5694%2Fmja15.01181" class="external text external">10.5694/mja15.01181</a><span class="reference-accessdate">. Retrieved <span class="nowrap">19 July</span> 2020</span>.</cite></span></li><li id="cite_note-3"> <span id="mw-reference-text-cite_note-3" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.medicines.org.uk/emc/product/6344/smpc  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.medicines.org.uk/emc/product/6344/smpc'" tppabs="https://www.medicines.org.uk/emc/product/6344/smpc" class="external text external">"Naloxone 400 micrograms/ml solution for Injection/Infusion - Summary of Product Characteristics (SmPC)"</a>. <i>(emc)</i>. 6 February 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">13 May</span> 2020</span>.</cite></span></li><li id="cite_note-AHFS2015-4"> <span id="mw-reference-text-cite_note-AHFS2015-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/naloxone-hydrochloride.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/naloxone-hydrochloride.html'" tppabs="https://www.drugs.com/monograph/naloxone-hydrochloride.html" class="external text external">"Naloxone Hydrochloride"</a>. The American Society of Health-System Pharmacists. <a href="javascript:if(confirm('https://web.archive.org/web/20150102115454/http://www.drugs.com/monograph/naloxone-hydrochloride.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150102115454/http://www.drugs.com/monograph/naloxone-hydrochloride.html'" tppabs="https://web.archive.org/web/20150102115454/http://www.drugs.com/monograph/naloxone-hydrochloride.html" class="external text external">Archived</a> from the original on 2015-01-02<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 2,</span> 2015</span>.</cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><cite id="CITEREFRoberts2014" class="citation book cs1">Roberts, James R. (2014). <a href="javascript:if(confirm('https://books.google.com/books?id=slyLreFkHuIC&pg=PA476  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=slyLreFkHuIC&pg=PA476'" tppabs="https://books.google.com/books?id=slyLreFkHuIC&pg=PA476" class="external text external"><i>Roberts and Hedges' clinical procedures in emergency medicine</i></a> (6 ed.). London: Elsevier Health Sciences. p.<span>&nbsp;</span>476. ISBN<span>&nbsp;</span><bdi>9781455748594</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170908140357/https://books.google.com/books?id=slyLreFkHuIC&pg=PA476  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170908140357/https://books.google.com/books?id=slyLreFkHuIC&pg=PA476'" tppabs="https://web.archive.org/web/20170908140357/https://books.google.com/books?id=slyLreFkHuIC&pg=PA476" class="external text external">Archived</a> from the original on 2017-09-08.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFBosack2015" class="citation book cs1">Bosack, Robert (2015). <a href="javascript:if(confirm('https://books.google.com/books?id=Rn51BwAAQBAJ&pg=PA191  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Rn51BwAAQBAJ&pg=PA191'" tppabs="https://books.google.com/books?id=Rn51BwAAQBAJ&pg=PA191" class="external text external"><i>Anesthesia Complications in the Dental Office</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>191. ISBN<span>&nbsp;</span><bdi>9781118828625</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170908140357/https://books.google.com/books?id=Rn51BwAAQBAJ&pg=PA191  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170908140357/https://books.google.com/books?id=Rn51BwAAQBAJ&pg=PA191'" tppabs="https://web.archive.org/web/20170908140357/https://books.google.com/books?id=Rn51BwAAQBAJ&pg=PA191" class="external text external">Archived</a> from the original on 2017-09-08.</cite></span></li><li id="cite_note-TGA2014-7"> <span id="mw-reference-text-cite_note-TGA2014-7" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.tga.gov.au/hp/medicines-pregnancy.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.tga.gov.au/hp/medicines-pregnancy.htm'" tppabs="http://www.tga.gov.au/hp/medicines-pregnancy.htm" class="external text external">"Prescribing medicines in pregnancy database"</a>. <i>Australian Government</i>. 3 March 2014. <a href="javascript:if(confirm('https://web.archive.org/web/20140408040902/http://www.tga.gov.au/hp/medicines-pregnancy.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140408040902/http://www.tga.gov.au/hp/medicines-pregnancy.htm'" tppabs="https://web.archive.org/web/20140408040902/http://www.tga.gov.au/hp/medicines-pregnancy.htm" class="external text external">Archived</a> from the original on 8 April 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">22 April</span> 2014</span>.</cite></span></li><li id="cite_note-NHM-Naloxone_pharmacology-8"> <span id="mw-reference-text-cite_note-NHM-Naloxone_pharmacology-8" class="mw-reference-text"><cite id="CITEREFMalenkaNestlerHyman2009" class="citation book cs1">Malenka RC, Nestler EJ, Hyman SE (2009).  Sydor A, Brown RY (ed.). <i>Molecular Neuropharmacology: A Foundation for Clinical Neuroscience</i> (2nd ed.). New York: McGraw-Hill Medical. pp.<span>&nbsp;</span>190–191, 287. ISBN<span>&nbsp;</span><bdi>9780071481274</bdi>. <q>Products of this research include the discovery of lipophilic, small-molecule opioid receptor antagonists, such as naloxone and naltrexone, which have been critical tools for investigating the physiology and behavioral actions of opiates.<span>&nbsp;</span>... A competitive antagonist of opiate action (naloxone) had been identified in early studies.<span>&nbsp;</span>... Opiate antagonists have clinical utility as well. Naloxone, a nonselective antagonist with a relative affinity of μ &gt; δ &gt; κ, is used to treat heroin and other opiate overdoses.</q></cite></span></li><li id="cite_note-Narcan_Prescribing_Information-9"> <span id="mw-reference-text-cite_note-Narcan_Prescribing_Information-9" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=724df050-5332-4d0a-9a5f-17bf08a547e1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=724df050-5332-4d0a-9a5f-17bf08a547e1'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=724df050-5332-4d0a-9a5f-17bf08a547e1" class="external text external">"Narcan- naloxone hydrochloride spray Narcan- naloxone hydrochloride spray"</a>. <i>DailyMed</i>. 7 October 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">12 May</span> 2020</span>.</cite></span></li><li id="cite_note-nyti_Jack-10"> <span id="mw-reference-text-cite_note-nyti_Jack-10" class="mw-reference-text"><cite id="CITEREFYardley2013" class="citation web cs1">Yardley, William (14 December 2013). <a href="javascript:if(confirm('https://www.nytimes.com/2013/12/15/business/jack-fishman-who-helped-develop-a-drug-to-treat-overdoses-dies-at-83.html?_r=0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2013/12/15/business/jack-fishman-who-helped-develop-a-drug-to-treat-overdoses-dies-at-83.html?_r=0'" tppabs="https://www.nytimes.com/2013/12/15/business/jack-fishman-who-helped-develop-a-drug-to-treat-overdoses-dies-at-83.html?_r=0" class="external text external">"Jack Fishman Dies at 83; Saved Many From Overdose"</a>. <i>New York Times</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20131215103845/http://www.nytimes.com/2013/12/15/business/jack-fishman-who-helped-develop-a-drug-to-treat-overdoses-dies-at-83.html?_r=0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20131215103845/http://www.nytimes.com/2013/12/15/business/jack-fishman-who-helped-develop-a-drug-to-treat-overdoses-dies-at-83.html?_r=0'" tppabs="https://web.archive.org/web/20131215103845/http://www.nytimes.com/2013/12/15/business/jack-fishman-who-helped-develop-a-drug-to-treat-overdoses-dies-at-83.html?_r=0" class="external text external">Archived</a> from the original on 15 December 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">2015-07-06</span></span>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><span class="citation patent" id="CITEREFJack_FishmanMozes_Juda_Lewenstein1970"><a href="javascript:if(confirm('https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19700203&CC=US&NR=3493657A&KC=A  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19700203&CC=US&NR=3493657A&KC=A'" tppabs="https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19700203&CC=US&NR=3493657A&KC=A" class="external text external">US<span> </span>patent 3493657</a>,<span> </span>Jack Fishman<span> </span><span>&amp;</span><span> </span>Mozes Juda Lewenstein,<span> </span>"Therapeutic compositions of n-allyl-14-hydroxy - dihydronormorphinane and morphine",<span> </span>published 1970-02-03,<span> </span>issued 1970-02-03,<span> </span> assigned to Mozes Juda Lewenstein</span></span></li><li id="cite_note-WHO21st-12"> <span id="mw-reference-text-cite_note-WHO21st-12" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2019" class="citation book cs1">World Health Organization (2019). <i>World Health Organization model list of essential medicines: 21st list 2019</i>. Geneva: World Health Organization. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F325771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F325771'" tppabs="https://hdl.handle.net/10665%2F325771" class="external text external">10665/325771</a></span>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</cite></span></li><li id="cite_note-special_circum_2015-13"> <span id="mw-reference-text-cite_note-special_circum_2015-13" class="mw-reference-text"><cite id="CITEREFLavonasDrennanGabrielliHeffner2015" class="citation journal cs1">Lavonas, EJ; Drennan, IR; Gabrielli, A; Heffner, AC; Hoyte, CO; Orkin, AM; Sawyer, KN; Donnino, MW (3 November 2015). "Part 10: Special Circumstances of Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care". <i>Circulation</i>. <b>132</b> (18 Suppl 2): S501-18. doi:<a href="javascript:if(confirm('https://doi.org/10.1161%2Fcir.0000000000000264  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161%2Fcir.0000000000000264'" tppabs="https://doi.org/10.1161%2Fcir.0000000000000264" class="external text external">10.1161/cir.0000000000000264</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26472998  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26472998'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26472998" class="external text external">26472998</a>.</cite></span></li><li id="cite_note-pmid16956873-14"> <span id="mw-reference-text-cite_note-pmid16956873-14" class="mw-reference-text"><cite id="CITEREFMaxwellBiggStanczykiewiczCarlberg-Racich2006" class="citation journal cs1">Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S (2006). "Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths". <i>J Addict Dis</i>. <b>25</b> (3): 89–96. doi:<a href="javascript:if(confirm('https://doi.org/10.1300%2FJ069v25n03_11  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1300%2FJ069v25n03_11'" tppabs="https://doi.org/10.1300%2FJ069v25n03_11" class="external text external">10.1300/J069v25n03_11</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16956873  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16956873'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16956873" class="external text external">16956873</a>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFLazarus_P2007" class="citation journal cs1">Lazarus P (2007). "Project Lazarus, Wilkes County, North Carolina: Policy Briefing Document Prepared for the North Carolina Medical Board in Advance of the Public Hearing Regarding Prescription Naloxone". Raleigh, NC.</cite><span> </span><span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code"><span>|</span>journal=</code> (help)</span></span></li><li id="cite_note-pmid23664112-16"> <span id="mw-reference-text-cite_note-pmid23664112-16" class="mw-reference-text"><cite id="CITEREFBowmanEisermanBeletskyStancliff2013" class="citation journal cs1">Bowman S, Eiserman J, Beletsky L, Stancliff S, Bruce RD (July 2013). "Reducing the health consequences of opioid addiction in primary care". <i>Am. J. Med</i>. <b>126</b> (7): 565–71. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.amjmed.2012.11.031  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.amjmed.2012.11.031'" tppabs="https://doi.org/10.1016%2Fj.amjmed.2012.11.031" class="external text external">10.1016/j.amjmed.2012.11.031</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23664112  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23664112'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23664112" class="external text external">23664112</a>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFBardsley2019" class="citation journal cs1">Bardsley, Russell (2019-10-30). "Higher naloxone dosing may be required for opioid overdose". <i>American Journal of Health-System Pharmacy</i>. <b>76</b> (22): 1835–1837. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Fajhp%2Fzxz208  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fajhp%2Fzxz208'" tppabs="https://doi.org/10.1093%2Fajhp%2Fzxz208" class="external text external">10.1093/ajhp/zxz208</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1535-2900  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1535-2900'" tppabs="https://www.worldcat.org/issn/1535-2900" class="external text external">1535-2900</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31665765  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31665765'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31665765" class="external text external">31665765</a>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20171117003258/https://www.uptodate.com/contents/naloxone-drug-information?source=search_result&search=Naloxone&selectedTitle=1~150  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20171117003258/https://www.uptodate.com/contents/naloxone-drug-information?source=search_result&search=Naloxone&selectedTitle=1~150#F199434'" tppabs="https://web.archive.org/web/20171117003258/https://www.uptodate.com/contents/naloxone-drug-information?source=search_result&search=Naloxone&selectedTitle=1~150#F199434" class="external text external">"Up To Date: Naloxone Monitoring Parameters"</a>. <i>Up to Date</i>. Archived from <a href="javascript:if(confirm('https://www.uptodate.com/contents/naloxone-drug-information?source=search_result&search=Naloxone&selectedTitle=1~150  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.uptodate.com/contents/naloxone-drug-information?source=search_result&search=Naloxone&selectedTitle=1~150#F199434'" tppabs="https://www.uptodate.com/contents/naloxone-drug-information?source=search_result&search=Naloxone&selectedTitle=1~150#F199434" class="external text external">the original</a> on 2017-11-17.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite id="CITEREFNiemannGetzugMurphy1986" class="citation journal cs1">Niemann, JT; Getzug, T; Murphy, W (October 1986). "Reversal of clonidine toxicity by naloxone". <i>Annals of Emergency Medicine</i>. <b>15</b> (10): 1229–31. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0196-0644%2886%2980874-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0196-0644%2886%2980874-5'" tppabs="https://doi.org/10.1016%2Fs0196-0644%2886%2980874-5" class="external text external">10.1016/s0196-0644(86)80874-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3752658  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3752658'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3752658" class="external text external">3752658</a>.</cite></span></li><li id="cite_note-Ahmad_et_al_2015_Review-20"> <span id="mw-reference-text-cite_note-Ahmad_et_al_2015_Review-20" class="mw-reference-text"><cite id="CITEREFAhmadScolnikSnehalGlatstein2015" class="citation journal cs1">Ahmad, Syed A.; Scolnik, Dennis; Snehal, Vala; Glatstein, Miguel (2015). "Use of Naloxone for Clonidine Intoxication in the Pediatric Age Group". <i>American Journal of Therapeutics</i>. <b>22</b> (1): e14–e16. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FMJT.0b013e318293b0e8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FMJT.0b013e318293b0e8'" tppabs="https://doi.org/10.1097%2FMJT.0b013e318293b0e8" class="external text external">10.1097/MJT.0b013e318293b0e8</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23782760  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23782760'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23782760" class="external text external">23782760</a>.</cite></span></li><li id="cite_note-Seger_DL_Review-21"> <span id="mw-reference-text-cite_note-Seger_DL_Review-21" class="mw-reference-text"><cite id="CITEREFSeger2002" class="citation journal cs1">Seger, DL (2002). "Clonidine toxicity revisited". <i>J Toxicol Clin Toxicol</i>. <b>40</b> (2): 145–155. doi:<a href="javascript:if(confirm('https://doi.org/10.1081%2FCLT-120004402  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1081%2FCLT-120004402'" tppabs="https://doi.org/10.1081%2FCLT-120004402" class="external text external">10.1081/CLT-120004402</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12126186  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12126186'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12126186" class="external text external">12126186</a>.</cite></span></li><li id="cite_note-Missouri_Poison_Control-22"> <span id="mw-reference-text-cite_note-Missouri_Poison_Control-22" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://missouripoisoncenter.org/wp-content/uploads/2015/02/2011-Clonidine.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://missouripoisoncenter.org/wp-content/uploads/2015/02/2011-Clonidine.pdf'" tppabs="https://missouripoisoncenter.org/wp-content/uploads/2015/02/2011-Clonidine.pdf" class="external text external">"Poison Alert: Clonidine"</a> <span class="cs1-format">(PDF)</span>. <i>missouripoisoncenter.org</i>. Missouri Poison Center<span class="reference-accessdate">. Retrieved <span class="nowrap">10 June</span> 2019</span>.</cite></span></li><li id="cite_note-Tennessee_Poison_Center-23"> <span id="mw-reference-text-cite_note-Tennessee_Poison_Center-23" class="mw-reference-text"><cite id="CITEREFLoden" class="citation web cs1">Loden, Justin. <a href="javascript:if(confirm('https://ww2.mc.vanderbilt.edu/poisoncenter/52552  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ww2.mc.vanderbilt.edu/poisoncenter/52552'" tppabs="https://ww2.mc.vanderbilt.edu/poisoncenter/52552" class="external text external">"Tennessee Poison Center - 03-26-18 Does naloxone reverse clonidine toxicity? - Vanderbilt Health Nashville, TN"</a>. <i>ww2.mc.vanderbilt.edu</i>. Tennessee Poison Center<span class="reference-accessdate">. Retrieved <span class="nowrap">10 June</span> 2019</span>.</cite></span></li><li id="cite_note-Orman2009-24"> <span id="mw-reference-text-cite_note-Orman2009-24" class="mw-reference-text"><cite id="CITEREFOrmanKeating2009" class="citation journal cs1">Orman, JS; Keating, GM (2009). "Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence". <i>Drugs</i>. <b>69</b> (5): 577–607. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-200969050-00006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-200969050-00006'" tppabs="https://doi.org/10.2165%2F00003495-200969050-00006" class="external text external">10.2165/00003495-200969050-00006</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19368419  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19368419'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19368419" class="external text external">19368419</a>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFBoefPoirier_VGauvin_FGuerguerian_AM2003" class="citation journal cs1">Boef, B; Poirier V; Gauvin F; Guerguerian AM; Roy C; Farrell CA; Lacroix J (2003). "Naloxone for shock". <i>Cochrane Database Syst Rev</i> (4): CD004443. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD004443  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD004443'" tppabs="https://doi.org/10.1002%2F14651858.CD004443" class="external text external">10.1002/14651858.CD004443</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14584016  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14584016'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14584016" class="external text external">14584016</a>.</cite></span></li><li id="cite_note-Protheroe's_Review-26"> <span id="mw-reference-text-cite_note-Protheroe's_Review-26" class="mw-reference-text"><cite id="CITEREFProtheroe1991" class="citation journal cs1">Protheroe, SM (1991). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1293421  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1293421'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1293421" class="external text external">"Congenital insensitivity to pain"</a>. <i>J R Soc Med</i>. <b>84</b> (9): 558–559. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F014107689108400918  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F014107689108400918'" tppabs="https://doi.org/10.1177%2F014107689108400918" class="external text external">10.1177/014107689108400918</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1293421  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1293421'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1293421" class="external text external">1293421</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1719200  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1719200'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1719200" class="external text external">1719200</a>.</cite></span></li><li id="cite_note-CIPA_Genetics_Home-27"> <span id="mw-reference-text-cite_note-CIPA_Genetics_Home-27" class="mw-reference-text"><cite id="CITEREFReference" class="citation web cs1">Reference, Genetics Home. <a href="javascript:if(confirm('https://ghr.nlm.nih.gov/condition/congenital-insensitivity-to-pain-with-anhidrosis  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ghr.nlm.nih.gov/condition/congenital-insensitivity-to-pain-with-anhidrosis'" tppabs="https://ghr.nlm.nih.gov/condition/congenital-insensitivity-to-pain-with-anhidrosis" class="external text external">"CIPA"</a>. <i>Genetics Home Reference</i>. U.S. National Library of Medicine<span class="reference-accessdate">. Retrieved <span class="nowrap">10 June</span> 2019</span>.</cite></span></li><li id="cite_note-:1-28"> <span id="mw-reference-text-cite_note-:1-28" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.uptodate.com/contents/naloxone-drug-information?source=search_result&search=naloxone&selectedTitle=1~150  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.uptodate.com/contents/naloxone-drug-information?source=search_result&search=naloxone&selectedTitle=1~150#F25732507'" tppabs="https://www.uptodate.com/contents/naloxone-drug-information?source=search_result&search=naloxone&selectedTitle=1~150#F25732507" class="external text external">"Naloxone"</a>. <i>www.uptodate.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2017-10-31</span></span>.</cite></span></li><li id="cite_note-pmid10601678-29"> <span id="mw-reference-text-cite_note-pmid10601678-29" class="mw-reference-text"><cite id="CITEREFMeissnerSchmidtHartmannKath2000" class="citation journal cs1">Meissner W, Schmidt U, Hartmann M, Kath R, Reinhart K (January 2000). "Oral naloxone reverses opioid-associated constipation". <i>Pain</i>. <b>84</b> (1): 105–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0304-3959%2899%2900185-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0304-3959%2899%2900185-2'" tppabs="https://doi.org/10.1016%2FS0304-3959%2899%2900185-2" class="external text external">10.1016/S0304-3959(99)00185-2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10601678  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10601678'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10601678" class="external text external">10601678</a>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite id="CITEREFSoborTimar,_J.Riba,_P.Kiraly,_KP.2013" class="citation journal cs1">Sobor, M; Timar, J.; Riba, P.; Kiraly, KP. (2013). "Behavioural studies during the gestational-lactation period in morphine treated rats". <i>Neuropsychopharmacol Hung</i>. <b>15</b> (4): 239–251. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24380965  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24380965'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24380965" class="external text external">24380965</a>.</cite></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.drugs.com/breastfeeding/naloxone.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/breastfeeding/naloxone.html'" tppabs="https://www.drugs.com/breastfeeding/naloxone.html" class="external text external">"Naloxone use while Breastfeeding"</a>. <i>Drugs.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2018-08-15</span></span>.</cite></span></li><li id="cite_note-32"> <span id="mw-reference-text-cite_note-32" class="mw-reference-text"><cite id="CITEREFMoe-ByrneBrownMcGuire2013" class="citation journal cs1">Moe-Byrne, Thirimon; Brown, Jennifer VE; McGuire, William (28 February 2013). "Naloxone for opiate-exposed newborn infants". <i>The Cochrane Library</i> (2): CD003483. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD003483.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD003483.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD003483.pub2" class="external text external">10.1002/14651858.CD003483.pub2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23450541  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23450541'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23450541" class="external text external">23450541</a>.</cite></span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text"><cite id="CITEREFMcGuireFowlieEvans2004" class="citation journal cs1">McGuire, William; Fowlie, Peter W; Evans, David J (2004-01-26). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485479  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485479'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485479" class="external text external">"Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia"</a>. <i>The Cochrane Library</i>. John Wiley &amp; Sons, Ltd (1): CD003955. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD003955.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD003955.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD003955.pub2" class="external text external">10.1002/14651858.CD003955.pub2</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1465-1858  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1465-1858'" tppabs="https://www.worldcat.org/issn/1465-1858" class="external text external">1465-1858</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485479  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485479'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485479" class="external text external">6485479</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14974047  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14974047'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14974047" class="external text external">14974047</a>.</cite></span></li><li id="cite_note-34"> <span id="mw-reference-text-cite_note-34" class="mw-reference-text"><cite id="CITEREFMoe-ByrneBrownMcGuire2018" class="citation journal cs1">Moe-Byrne, Thirimon; Brown, Jennifer Valeska Elli; McGuire, William (12 October 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517169  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517169'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517169" class="external text external">"Naloxone for opioid-exposed newborn infants"</a>. <i>Cochrane Database of Systematic Reviews</i>. <b>10</b>: CD003483. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD003483.pub3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD003483.pub3'" tppabs="https://doi.org/10.1002%2F14651858.CD003483.pub3" class="external text external">10.1002/14651858.CD003483.pub3</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517169  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517169'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517169" class="external text external">6517169</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30311212  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30311212'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30311212" class="external text external">30311212</a>.</cite></span></li><li id="cite_note-35"> <span id="mw-reference-text-cite_note-35" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.rxlist.com/narcan-drug.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rxlist.com/narcan-drug.htm'" tppabs="https://www.rxlist.com/narcan-drug.htm" class="external text external">"Narcan (Naloxone Hydrochloride Injection): Side Effects, Interactions, Warning, Dosage &amp; Uses"</a>. <i>RxList</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-10-24</span></span>.</cite></span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text"><a href="javascript:if(confirm('http://labeling.pfizer.com/ShowLabeling.aspx?id=4542  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://labeling.pfizer.com/ShowLabeling.aspx?id=4542'" tppabs="http://labeling.pfizer.com/ShowLabeling.aspx?id=4542" class="external free external">http://labeling.pfizer.com/ShowLabeling.aspx?id=4542</a></span></li><li id="cite_note-37"> <span id="mw-reference-text-cite_note-37" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/sfx/naloxone-side-effects.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/sfx/naloxone-side-effects.html'" tppabs="https://www.drugs.com/sfx/naloxone-side-effects.html" class="external text external">"Naloxone Side Effects in Detail"</a>. <i>Drugs.com</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20150507072325/http://www.drugs.com/sfx/naloxone-side-effects.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150507072325/http://www.drugs.com/sfx/naloxone-side-effects.html'" tppabs="https://web.archive.org/web/20150507072325/http://www.drugs.com/sfx/naloxone-side-effects.html" class="external text external">Archived</a> from the original on 7 May 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">5 May</span> 2015</span>.</cite></span></li><li id="cite_note-pmid3662194-38"> <span id="mw-reference-text-cite_note-pmid3662194-38" class="mw-reference-text"><cite id="CITEREFSchwartzKoenigsberg1987" class="citation journal cs1">Schwartz JA, Koenigsberg MD (November 1987). "Naloxone-induced pulmonary edema". <i>Ann Emerg Med</i>. <b>16</b> (11): 1294–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0196-0644%2887%2980244-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0196-0644%2887%2980244-5'" tppabs="https://doi.org/10.1016%2FS0196-0644%2887%2980244-5" class="external text external">10.1016/S0196-0644(87)80244-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3662194  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3662194'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3662194" class="external text external">3662194</a>.</cite></span></li><li id="cite_note-39"> <span id="mw-reference-text-cite_note-39" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.uptodate.com/contents/naloxone-drug-information?source=search_result&search=naloxone&selectedTitle=1~150  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.uptodate.com/contents/naloxone-drug-information?source=search_result&search=naloxone&selectedTitle=1~150#F199428'" tppabs="https://www.uptodate.com/contents/naloxone-drug-information?source=search_result&search=naloxone&selectedTitle=1~150#F199428" class="external text external">"Naloxone: Drug Information"</a>. <i>UpToDate</i>.</cite></span></li><li id="cite_note-pmid15820838-40"> <span id="mw-reference-text-cite_note-pmid15820838-40" class="mw-reference-text"><cite id="CITEREFSauroGreenberg2005" class="citation journal cs1">Sauro MD, Greenberg RP (February 2005). "Endogenous opiates and the placebo effect: a meta-analytic review". <i>J Psychosom Res</i>. <b>58</b> (2): 115–20. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jpsychores.2004.07.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jpsychores.2004.07.001'" tppabs="https://doi.org/10.1016%2Fj.jpsychores.2004.07.001" class="external text external">10.1016/j.jpsychores.2004.07.001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15820838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15820838'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15820838" class="external text external">15820838</a>.</cite></span></li><li id="cite_note-41"> <span id="mw-reference-text-cite_note-41" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('http://sitn.hms.harvard.edu/flash/2016/just-sugar-pill-placebo-effect-real/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://sitn.hms.harvard.edu/flash/2016/just-sugar-pill-placebo-effect-real/'" tppabs="http://sitn.hms.harvard.edu/flash/2016/just-sugar-pill-placebo-effect-real/" class="external text external">"More Than Just a Sugar Pill: Why the placebo effect is real - Science in the News"</a>. <i>Science in the News</i>. 2016-09-14<span class="reference-accessdate">. Retrieved <span class="nowrap">2017-11-14</span></span>.</cite></span></li><li id="cite_note-42"> <span id="mw-reference-text-cite_note-42" class="mw-reference-text"><cite id="CITEREFCarvalhoCaetanoCunhaRebouta2016" class="citation journal cs1">Carvalho, Cláudia; Caetano, Joaquim Machado; Cunha, Lidia; Rebouta, Paula; Kaptchuk, Ted J.; Kirsch, Irving (December 2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113234  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113234'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113234" class="external text external">"Open-label placebo treatment in chronic low back pain: a randomized controlled trial"</a>. <i>Pain</i>. <b>157</b> (12): 2766–2772. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2Fj.pain.0000000000000700  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2Fj.pain.0000000000000700'" tppabs="https://doi.org/10.1097%2Fj.pain.0000000000000700" class="external text external">10.1097/j.pain.0000000000000700</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1872-6623  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1872-6623'" tppabs="https://www.worldcat.org/issn/1872-6623" class="external text external">1872-6623</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113234  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113234'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113234" class="external text external">5113234</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27755279  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27755279'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27755279" class="external text external">27755279</a>.</cite></span></li><li id="cite_note-43"> <span id="mw-reference-text-cite_note-43" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.uptodate.com/contents/naloxone-drug-information?source=search_result&search=naloxone&selectedTitle=1~150  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.uptodate.com/contents/naloxone-drug-information?source=search_result&search=naloxone&selectedTitle=1~150#F199443'" tppabs="https://www.uptodate.com/contents/naloxone-drug-information?source=search_result&search=naloxone&selectedTitle=1~150#F199443" class="external text external">"Naloxone: Contraindications"</a>. <i>Up to Date</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2017-10-31</span></span>.</cite></span></li><li id="cite_note-:3-44"> <span id="mw-reference-text-cite_note-:3-44" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.pdr.net/drug-summary/Narcan-naloxone-hydrochloride-3837  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.pdr.net/drug-summary/Narcan-naloxone-hydrochloride-3837'" tppabs="https://www.pdr.net/drug-summary/Narcan-naloxone-hydrochloride-3837" class="external text external">"Narcan (naloxone hydrochloride) dose, indications, adverse effects, interactions... from PDR.net"</a>. <i>www.pdr.net</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-10-27</span></span>.</cite></span></li><li id="cite_note-pmid2986989-45"> <span id="mw-reference-text-cite_note-pmid2986989-45" class="mw-reference-text"><cite id="CITEREFTam1985" class="citation journal cs1">Tam SW (1985). "(+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes". <i>Eur. J. Pharmacol</i>. <b>109</b> (1): 33–41. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0014-2999%2885%2990536-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0014-2999%2885%2990536-9'" tppabs="https://doi.org/10.1016%2F0014-2999%2885%2990536-9" class="external text external">10.1016/0014-2999(85)90536-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2986989  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2986989'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2986989" class="external text external">2986989</a>.</cite></span></li><li id="cite_note-pmid7562497-46"> <span id="mw-reference-text-cite_note-pmid7562497-46" class="mw-reference-text"><cite id="CITEREFCoddShankSchupskyRaffa1995" class="citation journal cs1">Codd EE, Shank RP, Schupsky JJ, Raffa RB (September 1995). <a href="javascript:if(confirm('http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=7562497  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=7562497'" tppabs="http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=7562497" class="external text external">"Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception"</a>. <i>J. Pharmacol. Exp. Ther</i>. <b>274</b> (3): 1263–70. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7562497  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7562497'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7562497" class="external text external">7562497</a>.</cite></span></li><li id="cite_note-pmid8114680-47"> <span id="mw-reference-text-cite_note-pmid8114680-47" class="mw-reference-text"><cite id="CITEREFRaynorKongChenYasuda1994" class="citation journal cs1">Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, Reisine T (1994). <a href="javascript:if(confirm('http://molpharm.aspetjournals.org/content/45/2/330.short  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://molpharm.aspetjournals.org/content/45/2/330.short'" tppabs="http://molpharm.aspetjournals.org/content/45/2/330.short" class="external text external">"Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors"</a>. <i>Mol. Pharmacol</i>. <b>45</b> (2): 330–4. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8114680  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8114680'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8114680" class="external text external">8114680</a>.</cite></span></li><li id="cite_note-Naloxone_IUPHAR-48"> <span id="mw-reference-text-cite_note-Naloxone_IUPHAR-48" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1638  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1638'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1638" class="external text external">"Naloxone: Summary"</a>. <i>IUPHAR/BPS Guide to Pharmacology</i>. International Union of Basic and Clinical Pharmacology<span class="reference-accessdate">. Retrieved <span class="nowrap">15 November</span> 2017</span>. <q>The approved drug naloxone INN-assigned preparation is the (-)-enantiomer.<span>&nbsp;</span>... The (+) isomer is inactive at the opioid receptors. Marketed formulations may contain naloxone hydrochloride</q></cite></span></li><li id="cite_note-Opioid_receptor_family_–_IUPHAR-49"> <span id="mw-reference-text-cite_note-Opioid_receptor_family_–_IUPHAR-49" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=50  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=50'" tppabs="http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=50" class="external text external">"Opioid receptors: Introduction"</a>. <i>IUPHAR/BPS Guide to Pharmacology</i>. International Union of Basic and Clinical Pharmacology<span class="reference-accessdate">. Retrieved <span class="nowrap">15 November</span> 2017</span>. <q>The opioid antagonist, naloxone, which binds to μ, δ and κ receptors (with differing affinities), does not have significant affinity for the ORL1/LC132 receptor. These studies indicate that, from a pharmacological perspective, there are two major branches in the opioid peptide-N/OFQ receptor family: the main branch comprising the μ, δ and κ receptors, where naloxone acts as an antagonist; and a second branch with the receptor for N/OFQ, which has negligible affinity for naloxone.</q></cite></span></li><li id="cite_note-Daily_Med-50"> <span id="mw-reference-text-cite_note-Daily_Med-50" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8535cc84-ad4a-4d67-8480-fb5a2e3406f8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8535cc84-ad4a-4d67-8480-fb5a2e3406f8'" tppabs="http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8535cc84-ad4a-4d67-8480-fb5a2e3406f8" class="external text external">"Naloxone Hydrochloride injection, solution"</a>. Daily Med. <a href="javascript:if(confirm('https://web.archive.org/web/20140422232959/http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8535cc84-ad4a-4d67-8480-fb5a2e3406f8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140422232959/http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8535cc84-ad4a-4d67-8480-fb5a2e3406f8'" tppabs="https://web.archive.org/web/20140422232959/http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8535cc84-ad4a-4d67-8480-fb5a2e3406f8" class="external text external">Archived</a> from the original on 22 April 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">21 April</span> 2014</span>.</cite></span></li><li id="cite_note-51"> <span id="mw-reference-text-cite_note-51" class="mw-reference-text"><cite class="citation cs2"><a href="javascript:if(confirm('http://www.ncbi.nlm.nih.gov/books/NBK548244/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ncbi.nlm.nih.gov/books/NBK548244/'" tppabs="http://www.ncbi.nlm.nih.gov/books/NBK548244/" class="external text external">"Naloxone"</a>, <i>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury</i>, National Institute of Diabetes and Digestive and Kidney Diseases, 2012, PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31643568  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31643568'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31643568" class="external text external">31643568</a><span class="reference-accessdate">, retrieved <span class="nowrap">2019-10-30</span></span></cite></span></li><li id="cite_note-DeanBilsky2009-52"> <span id="mw-reference-text-cite_note-DeanBilsky2009-52" class="mw-reference-text"><cite id="CITEREFReginald_DeanEdward_J._BilskyS._Stevens_Negus2009" class="citation book cs1">Reginald Dean; Edward J. Bilsky; S. Stevens Negus (12 March 2009). <a href="javascript:if(confirm('https://books.google.com/books?id=zqj2vy6VFUcC&pg=PA514  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=zqj2vy6VFUcC&pg=PA514'" tppabs="https://books.google.com/books?id=zqj2vy6VFUcC&pg=PA514" class="external text external"><i>Opiate Receptors and Antagonists: From Bench to Clinic</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>514–. ISBN<span>&nbsp;</span><bdi>978-1-59745-197-0</bdi>.</cite></span></li><li id="cite_note-Nagase2011-53"> <span id="mw-reference-text-cite_note-Nagase2011-53" class="mw-reference-text"><cite id="CITEREFHiroshi_Nagase2011" class="citation book cs1">Hiroshi Nagase (21 January 2011). <a href="javascript:if(confirm('https://books.google.com/books?id=eegLBwAAQBAJ&pg=PA93  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=eegLBwAAQBAJ&pg=PA93'" tppabs="https://books.google.com/books?id=eegLBwAAQBAJ&pg=PA93" class="external text external"><i>Chemistry of Opioids</i></a>. Springer. pp.<span>&nbsp;</span>93–. ISBN<span>&nbsp;</span><bdi>978-3-642-18107-8</bdi>.</cite></span></li><li id="cite_note-NIST-54"> <span id="mw-reference-text-cite_note-NIST-54" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://webbook.nist.gov/cgi/cbook.cgi?ID=C465656  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://webbook.nist.gov/cgi/cbook.cgi?ID=C465656'" tppabs="http://webbook.nist.gov/cgi/cbook.cgi?ID=C465656" class="external text external">"Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5α)-"</a>.</cite></span></li><li id="cite_note-SeppalaRose2011-55"> <span id="mw-reference-text-cite_note-SeppalaRose2011-55" class="mw-reference-text"><cite id="CITEREFMarvin_D_SeppalaMark_E._Rose2011" class="citation book cs1">Marvin D Seppala; Mark E. Rose (25 January 2011). <a href="javascript:if(confirm('https://books.google.com/books?id=HkXXDQAAQBAJ&pg=PT143  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=HkXXDQAAQBAJ&pg=PT143'" tppabs="https://books.google.com/books?id=HkXXDQAAQBAJ&pg=PT143" class="external text external"><i>Prescription Painkillers: History, Pharmacology, and Treatment</i></a>. Hazelden Publishing. pp.<span>&nbsp;</span>143–. ISBN<span>&nbsp;</span><bdi>978-1-59285-993-1</bdi>.</cite></span></li><li id="cite_note-Bennett2006-56"> <span id="mw-reference-text-cite_note-Bennett2006-56" class="mw-reference-text"><cite id="CITEREFLouise_A._Bennett2006" class="citation book cs1">Louise A. Bennett (2006). <a href="javascript:if(confirm('https://books.google.com/books?id=aIDGy72xseMC&pg=PA9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=aIDGy72xseMC&pg=PA9'" tppabs="https://books.google.com/books?id=aIDGy72xseMC&pg=PA9" class="external text external"><i>New Topics in Substance Abuse Treatment</i></a>. Nova Publishers. pp.<span>&nbsp;</span>9–. ISBN<span>&nbsp;</span><bdi>978-1-59454-831-4</bdi>.</cite></span></li><li id="cite_note-Wang2003-57"> <span id="mw-reference-text-cite_note-Wang2003-57" class="mw-reference-text"><cite id="CITEREFJohn_Q._Wang2003" class="citation book cs1">John Q. Wang (2003). <a href="javascript:if(confirm('https://books.google.com/books?id=cuxYNGtzSTIC&pg=PA44  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=cuxYNGtzSTIC&pg=PA44'" tppabs="https://books.google.com/books?id=cuxYNGtzSTIC&pg=PA44" class="external text external"><i>Drugs of Abuse: Neurological Reviews and Protocols</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>44–. ISBN<span>&nbsp;</span><bdi>978-1-59259-358-3</bdi>.</cite></span></li><li id="cite_note-BruntonChabner2010-58"> <span id="mw-reference-text-cite_note-BruntonChabner2010-58" class="mw-reference-text"><cite id="CITEREFLaurence_BruntonBruce_ChabnerBjorn_Knollman2010" class="citation book cs1">Laurence Brunton; Bruce Chabner; Bjorn Knollman (20 December 2010). <a href="javascript:if(confirm('https://books.google.com/books?id=bVUfAQAAQBAJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=bVUfAQAAQBAJ'" tppabs="https://books.google.com/books?id=bVUfAQAAQBAJ" class="external text external"><i>Goodman and Gilman's The Pharmacological Basis of Therapeutics, Twelfth Edition</i></a>. McGraw Hill Professional. p.<span>&nbsp;</span>510. ISBN<span>&nbsp;</span><bdi>978-0-07-162442-8</bdi>.</cite></span></li><li id="cite_note-:2-59"> <span id="mw-reference-text-cite_note-:2-59" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('https://higherlogicdownload.s3.amazonaws.com/AAPS/bfc3a388-f31c-452f-88fd-941c2a445a10/UploadedImages/Press_Release_2018/Naloxone_-_AAPS_embargoed_release_Final.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://higherlogicdownload.s3.amazonaws.com/AAPS/bfc3a388-f31c-452f-88fd-941c2a445a10/UploadedImages/Press_Release_2018/Naloxone_-_AAPS_embargoed_release_Final.pdf'" tppabs="https://higherlogicdownload.s3.amazonaws.com/AAPS/bfc3a388-f31c-452f-88fd-941c2a445a10/UploadedImages/Press_Release_2018/Naloxone_-_AAPS_embargoed_release_Final.pdf" class="external text external">"New Study Indicates Opioid Overdose Reversal Products Chemically Stable Well Past Expiration: Extended Shelf-Life Has Potential for Stockpiles and Communities Date"</a> <span class="cs1-format">(PDF)</span> (Press release). American Association of Pharmaceutical Scientists. 6 November 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">8 November</span> 2018</span>.</cite></span></li><li id="cite_note-60"> <span id="mw-reference-text-cite_note-60" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016636  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016636'" tppabs="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016636" class="external text external">"Naloxone: FDA-Approved Drugs"</a>. <i>U.S. Food and Drug Administration (FDA)</i><span class="reference-accessdate">. Retrieved <span class="nowrap">13 May</span> 2020</span>.</cite></span></li><li id="cite_note-61"> <span id="mw-reference-text-cite_note-61" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('http://cordantsolutions.com/the-history-of-naloxone/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://cordantsolutions.com/the-history-of-naloxone/'" tppabs="http://cordantsolutions.com/the-history-of-naloxone/" class="external text external">"The History of Naloxone - Cordant Solutions"</a>. <i>Cordant Solutions</i>. 2017-07-05<span class="reference-accessdate">. Retrieved <span class="nowrap">2017-11-14</span></span>.</cite></span></li><li id="cite_note-Nyxoid_EPAR-62"> <span id="mw-reference-text-cite_note-Nyxoid_EPAR-62" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ema.europa.eu/en/medicines/human/EPAR/nyxoid  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ema.europa.eu/en/medicines/human/EPAR/nyxoid'" tppabs="https://www.ema.europa.eu/en/medicines/human/EPAR/nyxoid" class="external text external">"Nyxoid EPAR"</a>. <i>European Medicines Agency (EMA)</i><span class="reference-accessdate">. Retrieved <span class="nowrap">12 May</span> 2020</span>.</cite></span></li><li id="cite_note-Elks2014-63"> <span id="mw-reference-text-cite_note-Elks2014-63" class="mw-reference-text"><cite id="CITEREFJ._Elks2014" class="citation book cs1">J. Elks (14 November 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA851  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA851'" tppabs="https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA851" class="external text external"><i>The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies</i></a>. Springer. pp.<span>&nbsp;</span>851–. ISBN<span>&nbsp;</span><bdi>978-1-4757-2085-3</bdi>.</cite></span></li><li id="cite_note-IndexNominum2000-64"> <span id="mw-reference-text-cite_note-IndexNominum2000-64" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA715  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA715'" tppabs="https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA715" class="external text external"><i>Index Nominum 2000: International Drug Directory</i></a>. Taylor &amp; Francis. 2000. pp.<span>&nbsp;</span>715–. ISBN<span>&nbsp;</span><bdi>978-3-88763-075-1</bdi>.</cite></span></li><li id="cite_note-MortonHall2012-65"> <span id="mw-reference-text-cite_note-MortonHall2012-65" class="mw-reference-text"><cite id="CITEREFI.K._MortonJudith_M._Hall2012" class="citation book cs1">I.K. Morton; Judith M. Hall (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA189  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA189'" tppabs="https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA189" class="external text external"><i>Concise Dictionary of Pharmacological Agents: Properties and Synonyms</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>189–. ISBN<span>&nbsp;</span><bdi>978-94-011-4439-1</bdi>.</cite></span></li><li id="cite_note-Drugs.com-66"> <span id="mw-reference-text-cite_note-Drugs.com-66" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/naloxone.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/naloxone.html'" tppabs="https://www.drugs.com/international/naloxone.html" class="external text external">"Naloxone"</a>.</cite></span></li><li id="cite_note-Lexicomp._2013-67"> <span id="mw-reference-text-cite_note-Lexicomp._2013-67" class="mw-reference-text"><cite id="CITEREFLexicomp.2013" class="citation book cs1">Lexicomp. (2013). <i>Drug information handbook for advanced practice nursing<span>&nbsp;</span>: a comprehensive resource for nurse practitioners, nurse midwives and clinical specialists, including selected disease management guidelines</i>. Lexicomp. ISBN<span>&nbsp;</span><bdi>978-1591953234</bdi>. OCLC<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/oclc/827841946  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/oclc/827841946'" tppabs="https://www.worldcat.org/oclc/827841946" class="external text external">827841946</a>.</cite></span></li><li id="cite_note-68"> <span id="mw-reference-text-cite_note-68" class="mw-reference-text">Naloxone for Treatment of Opioide Overdose Advisory 2016</span></li><li id="cite_note-:0-69"> <span id="mw-reference-text-cite_note-:0-69" class="mw-reference-text">Naloxone for Treatment of Opioid Overdose Oct. 2016</span></li><li id="cite_note-FDA_News_Release-70"> <span id="mw-reference-text-cite_note-FDA_News_Release-70" class="mw-reference-text"><cite id="CITEREFFDA_News_Release" class="citation web cs1">FDA News Release. <a href="javascript:if(confirm('https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm391465.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm391465.htm'" tppabs="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm391465.htm" class="external text external">"FDA approves new hand-held auto-injector to reverse opioid overdose"</a>. <i>FDA.gov</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20150716003000/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm391465.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150716003000/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm391465.htm'" tppabs="https://web.archive.org/web/20150716003000/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm391465.htm" class="external text external">Archived</a> from the original on 2015-07-16<span class="reference-accessdate">. Retrieved <span class="nowrap">2015-07-20</span></span>.</cite></span></li><li id="cite_note-:5-71"> <span id="mw-reference-text-cite_note-:5-71" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://ndclist.com/ndc/72853-051/package/72853-051-02  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ndclist.com/ndc/72853-051/package/72853-051-02'" tppabs="https://ndclist.com/ndc/72853-051/package/72853-051-02" class="external text external">"NDC 72853-051-02 Naloxone Hydrochloride Auto-injector"</a>. <i>NDClist.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-03-21</span></span>.</cite></span></li><li id="cite_note-72"> <span id="mw-reference-text-cite_note-72" class="mw-reference-text"><cite id="CITEREFCommissioner2019" class="citation web cs1">Commissioner, Office of the (2019-09-11). <a href="javascript:if(confirm('https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-naloxone-nasal-spray-treat-opioid-overdose  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-naloxone-nasal-spray-treat-opioid-overdose'" tppabs="https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-naloxone-nasal-spray-treat-opioid-overdose" class="external text external">"FDA approves first generic naloxone nasal spray to treat opioid overdose"</a>. <i>FDA</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-10-23</span></span>.</cite></span></li><li id="cite_note-73"> <span id="mw-reference-text-cite_note-73" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.jems.com/articles/2015/11/fda-approves-narcan-nasal-spray.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.jems.com/articles/2015/11/fda-approves-narcan-nasal-spray.html'" tppabs="http://www.jems.com/articles/2015/11/fda-approves-narcan-nasal-spray.html" class="external text external">"FDA Approves Narcan Nasal Spray"</a>. <i>www.jems.com</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20151120184918/http://www.jems.com/articles/2015/11/fda-approves-narcan-nasal-spray.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20151120184918/http://www.jems.com/articles/2015/11/fda-approves-narcan-nasal-spray.html'" tppabs="https://web.archive.org/web/20151120184918/http://www.jems.com/articles/2015/11/fda-approves-narcan-nasal-spray.html" class="external text external">Archived</a> from the original on 2015-11-20<span class="reference-accessdate">. Retrieved <span class="nowrap">2015-11-21</span></span>.</cite></span></li><li id="cite_note-74"> <span id="mw-reference-text-cite_note-74" class="mw-reference-text"><cite id="CITEREFVolkow2015" class="citation web cs1">Volkow, Nora (18 November 2015). <a href="javascript:if(confirm('https://www.drugabuse.gov/about-nida/noras-blog/2015/11/narcan-nasal-spray-life-saving-science-nida  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugabuse.gov/about-nida/noras-blog/2015/11/narcan-nasal-spray-life-saving-science-nida'" tppabs="https://www.drugabuse.gov/about-nida/noras-blog/2015/11/narcan-nasal-spray-life-saving-science-nida" class="external text external">"NARCAN Nasal Spray: Life Saving Science at NIDA"</a>. <i>DrugAbuse.gov—"Nora's Blog"</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20170226133910/https://www.drugabuse.gov/about-nida/noras-blog/2015/11/narcan-nasal-spray-life-saving-science-nida  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170226133910/https://www.drugabuse.gov/about-nida/noras-blog/2015/11/narcan-nasal-spray-life-saving-science-nida'" tppabs="https://web.archive.org/web/20170226133910/https://www.drugabuse.gov/about-nida/noras-blog/2015/11/narcan-nasal-spray-life-saving-science-nida" class="external text external">Archived</a> from the original on 2017-02-26.</cite></span></li><li id="cite_note-75"> <span id="mw-reference-text-cite_note-75" class="mw-reference-text"><cite id="CITEREFBrady_Dennis2014" class="citation news cs1">Brady Dennis (3 April 2014). <a href="javascript:if(confirm('https://www.washingtonpost.com/national/health-science/fda-approves-device-to-combat-opiod-drug-overdose/2014/04/03/35b69cac-bb3e-11e3-96ae-f2c36d2b1245_story.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.washingtonpost.com/national/health-science/fda-approves-device-to-combat-opiod-drug-overdose/2014/04/03/35b69cac-bb3e-11e3-96ae-f2c36d2b1245_story.html'" tppabs="https://www.washingtonpost.com/national/health-science/fda-approves-device-to-combat-opiod-drug-overdose/2014/04/03/35b69cac-bb3e-11e3-96ae-f2c36d2b1245_story.html" class="external text external">"FDA approves device to combat opioid drug overdose"</a>. <i>The Washington Post</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20140407173215/http://www.washingtonpost.com/national/health-science/fda-approves-device-to-combat-opiod-drug-overdose/2014/04/03/35b69cac-bb3e-11e3-96ae-f2c36d2b1245_story.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140407173215/http://www.washingtonpost.com/national/health-science/fda-approves-device-to-combat-opiod-drug-overdose/2014/04/03/35b69cac-bb3e-11e3-96ae-f2c36d2b1245_story.html'" tppabs="https://web.archive.org/web/20140407173215/http://www.washingtonpost.com/national/health-science/fda-approves-device-to-combat-opiod-drug-overdose/2014/04/03/35b69cac-bb3e-11e3-96ae-f2c36d2b1245_story.html" class="external text external">Archived</a> from the original on 7 April 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">8 April</span> 2014</span>.</cite></span></li><li id="cite_note-76"> <span id="mw-reference-text-cite_note-76" class="mw-reference-text"><cite class="citation web cs1">Commissioner, Office of the (2019-04-19). <a href="javascript:if(confirm('https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm636333.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm636333.htm'" tppabs="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm636333.htm" class="external text external">"Press Announcements - FDA approves first generic naloxone nasal spray to treat opioid overdose"</a>. <i>www.fda.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">23 April</span> 2019</span>.</cite></span></li><li id="cite_note-pmid15039670-77"> <span id="mw-reference-text-cite_note-pmid15039670-77" class="mw-reference-text"><cite id="CITEREFWolfeBernstone2004" class="citation journal cs1">Wolfe TR, Bernstone T (April 2004). "Intranasal drug delivery: an alternative to intravenous administration in selected emergency cases". <i>J Emerg Nurs</i>. <b>30</b> (2): 141–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jen.2004.01.006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jen.2004.01.006'" tppabs="https://doi.org/10.1016%2Fj.jen.2004.01.006" class="external text external">10.1016/j.jen.2004.01.006</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15039670  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15039670'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15039670" class="external text external">15039670</a>.</cite></span></li><li id="cite_note-78"> <span id="mw-reference-text-cite_note-78" class="mw-reference-text"><cite id="CITEREFFiore2015" class="citation web cs1">Fiore, Kristina (2015-06-13). <a href="javascript:if(confirm('http://www.medpagetoday.com/PublicHealthPolicy/PublicHealth/52118  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medpagetoday.com/PublicHealthPolicy/PublicHealth/52118'" tppabs="http://www.medpagetoday.com/PublicHealthPolicy/PublicHealth/52118" class="external text external">"On-Label Nasal Naloxone in the Works"</a>. <i>MedPage Today</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20150801184056/http://www.medpagetoday.com/PublicHealthPolicy/PublicHealth/52118  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150801184056/http://www.medpagetoday.com/PublicHealthPolicy/PublicHealth/52118'" tppabs="https://web.archive.org/web/20150801184056/http://www.medpagetoday.com/PublicHealthPolicy/PublicHealth/52118" class="external text external">Archived</a> from the original on 2015-08-01<span class="reference-accessdate">. Retrieved <span class="nowrap">2015-07-20</span></span>.</cite></span></li><li id="cite_note-79"> <span id="mw-reference-text-cite_note-79" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=5fbe8d17-a72f-406d-a736-48e61620f9d8&type=display  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=5fbe8d17-a72f-406d-a736-48e61620f9d8&type=display#s_ppi'" tppabs="https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=5fbe8d17-a72f-406d-a736-48e61620f9d8&type=display#s_ppi" class="external text external">"These highlights do not include all the information needed to use EVZIO® safely and effectively. See full prescribing information for EVZIO. EVZIO® (naloxone hydrochloride injection) Auto-Injector for intramuscular or subcutaneous use 2 mg Initial U.S. Approval: 1971"</a>. <i>dailymed.nlm.nih.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-10-31</span></span>.</cite></span></li><li id="cite_note-CohenMahoney2020-80"> <span id="mw-reference-text-cite_note-CohenMahoney2020-80" class="mw-reference-text"><cite id="CITEREFCohenMahoneyBaroSquire2020" class="citation journal cs1">Cohen, Barbara R.; Mahoney, Karen M.; Baro, Elande; Squire, Claudia; Beck, Melissa; Travis, Sara; Pike-McCrudden, Amanda; Izem, Rima; Woodcock, Janet (2020). "FDA Initiative for Drug Facts Label for Over-the-Counter Naloxone". <i>New England Journal of Medicine</i>. <b>382</b> (22): 2129–2136. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMsa1912403  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMsa1912403'" tppabs="https://doi.org/10.1056%2FNEJMsa1912403" class="external text external">10.1056/NEJMsa1912403</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0028-4793  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0028-4793'" tppabs="https://www.worldcat.org/issn/0028-4793" class="external text external">0028-4793</a>.</cite></span></li><li id="cite_note-81"> <span id="mw-reference-text-cite_note-81" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://cvshealth.com/thought-leadership/naloxone-opioid-overdose-reversal-medication  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://cvshealth.com/thought-leadership/naloxone-opioid-overdose-reversal-medication'" tppabs="https://cvshealth.com/thought-leadership/naloxone-opioid-overdose-reversal-medication" class="external text external">"Naloxone Opioid Overdose Reversal Medication"</a>. <i>CVS Health</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2018-09-19</span></span>.</cite></span></li><li id="cite_note-82"> <span id="mw-reference-text-cite_note-82" class="mw-reference-text"><cite id="CITEREFEagle" class="citation news cs1">Eagle, Chrissy Suttles, Wyoming Tribune. <a href="javascript:if(confirm('https://www.wyomingnews.com/news/local_news/wyoming-s-albertsons-safeway-pharmacies-to-offer-narcan-over-the/article_ca4b259c-08ae-11e8-9f50-17a75174a10d.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wyomingnews.com/news/local_news/wyoming-s-albertsons-safeway-pharmacies-to-offer-narcan-over-the/article_ca4b259c-08ae-11e8-9f50-17a75174a10d.html'" tppabs="https://www.wyomingnews.com/news/local_news/wyoming-s-albertsons-safeway-pharmacies-to-offer-narcan-over-the/article_ca4b259c-08ae-11e8-9f50-17a75174a10d.html" class="external text external">"Wyoming's Albertsons, Safeway pharmacies to offer Narcan over the counter"</a>. <i>Wyoming Tribune Eagle</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2018-09-19</span></span>.</cite></span></li><li id="cite_note-83"> <span id="mw-reference-text-cite_note-83" class="mw-reference-text"><cite id="CITEREFMeyersonAgleyDavisJayawardene2018" class="citation journal cs1">Meyerson, B.E.; Agley, J.D.; Davis, A.; Jayawardene, W.; Hoss, A.; Shannon, D.J.; Ryder, P.T.; Ritchie, K.; Gassman, R. (July 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375076  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375076'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375076" class="external text external">"Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016"</a>. <i>Drug and Alcohol Dependence</i>. <b>188</b>: 187–192. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.drugalcdep.2018.03.032  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.drugalcdep.2018.03.032'" tppabs="https://doi.org/10.1016%2Fj.drugalcdep.2018.03.032" class="external text external">10.1016/j.drugalcdep.2018.03.032</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375076  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375076'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375076" class="external text external">6375076</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29778772  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29778772'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29778772" class="external text external">29778772</a>.</cite></span></li><li id="cite_note-84"> <span id="mw-reference-text-cite_note-84" class="mw-reference-text"><cite id="CITEREFMeyersonAgleyJayawardeneEldridge2019" class="citation journal cs1">Meyerson, B.E.; Agley, J.D.; Jayawardene, W.; Eldridge, L.A.; Arora, P.; Smith, C.; Vadiei, N.; Kennedy, A.; Moehling, T. (August 2019). <a href="javascript:if(confirm('https://doi.org/10.1016/j.sapharm.2019.08.026  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.sapharm.2019.08.026'" tppabs="https://doi.org/10.1016/j.sapharm.2019.08.026" class="external text external">"Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C"</a>. <i>Research in Social and Administrative Pharmacy</i>. <b>16</b> (5): 699–709. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.sapharm.2019.08.026  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.sapharm.2019.08.026'" tppabs="https://doi.org/10.1016%2Fj.sapharm.2019.08.026" class="external text external">10.1016/j.sapharm.2019.08.026</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31611071  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31611071'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31611071" class="external text external">31611071</a>.</cite></span></li><li id="cite_note-85"> <span id="mw-reference-text-cite_note-85" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.nchrc.org/law-enforcement/us-law-enforcement-who-carry-naloxone/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nchrc.org/law-enforcement/us-law-enforcement-who-carry-naloxone/'" tppabs="http://www.nchrc.org/law-enforcement/us-law-enforcement-who-carry-naloxone/" class="external text external">"US Law Enforcement Who Carry Naloxone"</a>. <i>North Carolina Harm Reduction Coalition</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20150713032125/http://www.nchrc.org/law-enforcement/us-law-enforcement-who-carry-naloxone/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150713032125/http://www.nchrc.org/law-enforcement/us-law-enforcement-who-carry-naloxone/'" tppabs="https://web.archive.org/web/20150713032125/http://www.nchrc.org/law-enforcement/us-law-enforcement-who-carry-naloxone/" class="external text external">Archived</a> from the original on 13 July 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">12 July</span> 2015</span>.</cite></span></li><li id="cite_note-86"> <span id="mw-reference-text-cite_note-86" class="mw-reference-text"><cite id="CITEREFMelissa_Davey2016" class="citation news cs1">Melissa Davey (29 January 2016). <a href="javascript:if(confirm('https://www.theguardian.com/society/2016/jan/29/selling-opioid-overdose-antidote-naloxone-over-counter-will-save-lives  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.theguardian.com/society/2016/jan/29/selling-opioid-overdose-antidote-naloxone-over-counter-will-save-lives'" tppabs="https://www.theguardian.com/society/2016/jan/29/selling-opioid-overdose-antidote-naloxone-over-counter-will-save-lives" class="external text external">"Selling opioid overdose antidote Naloxone over counter 'will save lives<span class="cs1-kern-right">'</span>"</a>. <i>The Guardian</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20161203055245/https://www.theguardian.com/society/2016/jan/29/selling-opioid-overdose-antidote-naloxone-over-counter-will-save-lives  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161203055245/https://www.theguardian.com/society/2016/jan/29/selling-opioid-overdose-antidote-naloxone-over-counter-will-save-lives'" tppabs="https://web.archive.org/web/20161203055245/https://www.theguardian.com/society/2016/jan/29/selling-opioid-overdose-antidote-naloxone-over-counter-will-save-lives" class="external text external">Archived</a> from the original on 3 December 2016.</cite></span></li><li id="cite_note-87"> <span id="mw-reference-text-cite_note-87" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.abc.net.au/triplej/programs/hack/how-painkiller-use-becomes-a-heroin-addiction/7129964  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.abc.net.au/triplej/programs/hack/how-painkiller-use-becomes-a-heroin-addiction/7129964'" tppabs="http://www.abc.net.au/triplej/programs/hack/how-painkiller-use-becomes-a-heroin-addiction/7129964" class="external text external">"Why the 'heroin antidote' naloxone is now available in pharmacies"</a>. ABC. 1 February 2016. <a href="javascript:if(confirm('https://web.archive.org/web/20160204040604/http://www.abc.net.au/triplej/programs/hack/how-painkiller-use-becomes-a-heroin-addiction/7129964  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160204040604/http://www.abc.net.au/triplej/programs/hack/how-painkiller-use-becomes-a-heroin-addiction/7129964'" tppabs="https://web.archive.org/web/20160204040604/http://www.abc.net.au/triplej/programs/hack/how-painkiller-use-becomes-a-heroin-addiction/7129964" class="external text external">Archived</a> from the original on 4 February 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">1 February</span> 2016</span>.</cite></span></li><li id="cite_note-88"> <span id="mw-reference-text-cite_note-88" class="mw-reference-text"><cite id="CITEREFCoulter2019" class="citation web cs1">Coulter, Ellen (27 August 2019). <a href="javascript:if(confirm('https://www.abc.net.au/news/2019-08-27/naloxone-can-stop-an-overdose-why-arent-people-using-it/11448540  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.abc.net.au/news/2019-08-27/naloxone-can-stop-an-overdose-why-arent-people-using-it/11448540'" tppabs="https://www.abc.net.au/news/2019-08-27/naloxone-can-stop-an-overdose-why-arent-people-using-it/11448540" class="external text external">"This drug can temporarily reverse an opioid overdose. So why aren't people using it?"</a>. <i>ABC News</i><span class="reference-accessdate">. Retrieved <span class="nowrap">28 August</span> 2019</span>.</cite></span></li><li id="cite_note-89"> <span id="mw-reference-text-cite_note-89" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.cbc.ca/news/health/naloxone-s-prescription-only-status-to-get-health-canada-review-1.3166867  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cbc.ca/news/health/naloxone-s-prescription-only-status-to-get-health-canada-review-1.3166867'" tppabs="https://www.cbc.ca/news/health/naloxone-s-prescription-only-status-to-get-health-canada-review-1.3166867" class="external text external">"Naloxone's prescription-only status to get Health Canada review"</a>. <i>CBC News</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20160205205030/https://www.cbc.ca/news/health/naloxone-s-prescription-only-status-to-get-health-canada-review-1.3166867  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160205205030/https://www.cbc.ca/news/health/naloxone-s-prescription-only-status-to-get-health-canada-review-1.3166867'" tppabs="https://web.archive.org/web/20160205205030/https://www.cbc.ca/news/health/naloxone-s-prescription-only-status-to-get-health-canada-review-1.3166867" class="external text external">Archived</a> from the original on 2016-02-05<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-02-05</span></span>.</cite></span></li><li id="cite_note-90"> <span id="mw-reference-text-cite_note-90" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20160205142858/http://www.health.alberta.ca/health-info/AMH-Naloxone-Take-home.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160205142858/http://www.health.alberta.ca/health-info/AMH-Naloxone-Take-home.html'" tppabs="https://web.archive.org/web/20160205142858/http://www.health.alberta.ca/health-info/AMH-Naloxone-Take-home.html" class="external text external">"Fentanyl and the take-home naloxone program Alberta Health"</a>. Archived from <a href="javascript:if(confirm('http://www.health.alberta.ca/health-info/AMH-Naloxone-Take-home.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.health.alberta.ca/health-info/AMH-Naloxone-Take-home.html'" tppabs="http://www.health.alberta.ca/health-info/AMH-Naloxone-Take-home.html" class="external text external">the original</a> on 2016-02-05<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-02-05</span></span>.</cite></span></li><li id="cite_note-91"> <span id="mw-reference-text-cite_note-91" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20170110031441/http://news.gc.ca/web/article-en.do?nid=1027679  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170110031441/http://news.gc.ca/web/article-en.do?nid=1027679'" tppabs="https://web.archive.org/web/20170110031441/http://news.gc.ca/web/article-en.do?nid=1027679" class="external text external">"Health Canada Statement on Change in Federal Prescription Status of Naloxone"</a>. <i>news.gc.ca</i>. January 14, 2016. Archived from <a href="javascript:if(confirm('http://news.gc.ca/web/article-en.do?nid=1027679  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://news.gc.ca/web/article-en.do?nid=1027679'" tppabs="http://news.gc.ca/web/article-en.do?nid=1027679" class="external text external">the original</a> on January 10, 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">February 29,</span> 2016</span> <span>–</span> via Wayback Machine.</cite></span></li><li id="cite_note-92"> <span id="mw-reference-text-cite_note-92" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.hc-sc.gc.ca/dhp-mps/prodpharma/pdl-ord/pdl-ldo-qa-naloxone-qr-eng.php  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.hc-sc.gc.ca/dhp-mps/prodpharma/pdl-ord/pdl-ldo-qa-naloxone-qr-eng.php'" tppabs="http://www.hc-sc.gc.ca/dhp-mps/prodpharma/pdl-ord/pdl-ldo-qa-naloxone-qr-eng.php" class="external text external">"Questions and Answers - Naloxone"</a>. <i>Health Canada</i>. March 22, 2017. <a href="javascript:if(confirm('https://web.archive.org/web/20170908140357/http://www.hc-sc.gc.ca/dhp-mps/prodpharma/pdl-ord/pdl-ldo-qa-naloxone-qr-eng.php  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170908140357/http://www.hc-sc.gc.ca/dhp-mps/prodpharma/pdl-ord/pdl-ldo-qa-naloxone-qr-eng.php'" tppabs="https://web.archive.org/web/20170908140357/http://www.hc-sc.gc.ca/dhp-mps/prodpharma/pdl-ord/pdl-ldo-qa-naloxone-qr-eng.php" class="external text external">Archived</a> from the original on September 8, 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">June 12,</span> 2017</span>.</cite></span></li><li id="cite_note-93"> <span id="mw-reference-text-cite_note-93" class="mw-reference-text"><cite id="CITEREFCorey_Davis" class="citation journal cs1">Corey Davis. <a href="javascript:if(confirm('https://www.networkforphl.org/_asset/qz5pvn/network-naloxone-10-4.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.networkforphl.org/_asset/qz5pvn/network-naloxone-10-4.pdf'" tppabs="https://www.networkforphl.org/_asset/qz5pvn/network-naloxone-10-4.pdf" class="external text external">"Legal interventions to reduce overdose mortality: Naloxone access and overdose good samaritan laws"</a> <span class="cs1-format">(PDF)</span>. <i>Network for Public Health Law</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20140903114828/https://www.networkforphl.org/_asset/qz5pvn/network-naloxone-10-4.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140903114828/https://www.networkforphl.org/_asset/qz5pvn/network-naloxone-10-4.pdf'" tppabs="https://web.archive.org/web/20140903114828/https://www.networkforphl.org/_asset/qz5pvn/network-naloxone-10-4.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 2014-09-03.</cite></span></li><li id="cite_note-94"> <span id="mw-reference-text-cite_note-94" class="mw-reference-text"><cite id="CITEREFDavisWebbBurris2013" class="citation journal cs1">Davis CS, Webb D, Burris SC (2013). "Changing Law from Barrier to Facilitator of Opioid Overdose Prevention". <i>Journal of Law, Medicine and Ethics</i>. <b>41</b>: 33–36. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fjlme.12035  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fjlme.12035'" tppabs="https://doi.org/10.1111%2Fjlme.12035" class="external text external">10.1111/jlme.12035</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23590737  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23590737'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23590737" class="external text external">23590737</a>.</cite></span></li><li id="cite_note-95"> <span id="mw-reference-text-cite_note-95" class="mw-reference-text">Ryan Oftebro, <a href="javascript:if(confirm('https://www.krrph.com/kelley-ross-pharmacy-provides-take-home-naloxone-to-prevent-opioid-overdose/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.krrph.com/kelley-ross-pharmacy-provides-take-home-naloxone-to-prevent-opioid-overdose/'" tppabs="https://www.krrph.com/kelley-ross-pharmacy-provides-take-home-naloxone-to-prevent-opioid-overdose/" class="external text external">"Kelley-Ross Pharmacy provides Take-Home Naloxone to prevent opioid overdose"</a> <a href="javascript:if(confirm('https://web.archive.org/web/20140519022951/https://www.krrph.com/kelley-ross-pharmacy-provides-take-home-naloxone-to-prevent-opioid-overdose/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140519022951/https://www.krrph.com/kelley-ross-pharmacy-provides-take-home-naloxone-to-prevent-opioid-overdose/'" tppabs="https://web.archive.org/web/20140519022951/https://www.krrph.com/kelley-ross-pharmacy-provides-take-home-naloxone-to-prevent-opioid-overdose/" class="external text external">Archived</a><span> 2014-05-19 at the </span>Wayback Machine, <i>Kelley-Ross</i>, August 20, 2013</span></li><li id="cite_note-Beletsky_2009-96"> <span id="mw-reference-text-cite_note-Beletsky_2009-96" class="mw-reference-text"><cite id="CITEREFBeletskyBurrisKral2009" class="citation journal cs1">Beletsky L, Burris SC, Kral AH (2009). "Closing Death's Door: Action Steps to Facilitate Emergency Opioid Drug Overdose Reversal in the United States". doi:<a href="javascript:if(confirm('https://doi.org/10.2139%2Fssrn.1437163  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2139%2Fssrn.1437163'" tppabs="https://doi.org/10.2139%2Fssrn.1437163" class="external text external">10.2139/ssrn.1437163</a>.</cite><span> </span><span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code"><span>|</span>journal=</code> (help)</span></span></li><li id="cite_note-97"> <span id="mw-reference-text-cite_note-97" class="mw-reference-text"><cite id="CITEREFBurrisBeletskyCastagnaCoyle2009" class="citation journal cs1">Burris SC, Beletsky L, Castagna CA, Coyle C, Crowe C, McLaughlin JM (2009). "Stopping an Invisible Epidemic: Legal Issues in the Provision of Naloxone to Prevent Opioid Overdose". doi:<a href="javascript:if(confirm('https://doi.org/10.2139%2Fssrn.1434381  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2139%2Fssrn.1434381'" tppabs="https://doi.org/10.2139%2Fssrn.1434381" class="external text external">10.2139/ssrn.1434381</a>.</cite><span> </span><span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code"><span>|</span>journal=</code> (help)</span></span></li><li id="cite_note-:4-98"> <span id="mw-reference-text-cite_note-:4-98" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.pharmacytimes.com/contributor/marilyn-bulloch-pharmd-bcps/2016/10/as-naloxone-accessibility-increases-pharmacists-role-expands  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.pharmacytimes.com/contributor/marilyn-bulloch-pharmd-bcps/2016/10/as-naloxone-accessibility-increases-pharmacists-role-expands'" tppabs="https://www.pharmacytimes.com/contributor/marilyn-bulloch-pharmd-bcps/2016/10/as-naloxone-accessibility-increases-pharmacists-role-expands" class="external text external">"As Naloxone Accessibility Increases, Pharmacist's Role Expands"</a>. <i>Pharmacy Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-10-31</span></span>.</cite></span></li><li id="cite_note-99"> <span id="mw-reference-text-cite_note-99" class="mw-reference-text"><cite id="CITEREFJessica_Durando2014" class="citation news cs1">Jessica Durando (27 May 2014). <a href="javascript:if(confirm('https://www.usatoday.com/story/news/nation-now/2014/05/27/new-york-police-department-naloxone/9630299/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.usatoday.com/story/news/nation-now/2014/05/27/new-york-police-department-naloxone/9630299/'" tppabs="https://www.usatoday.com/story/news/nation-now/2014/05/27/new-york-police-department-naloxone/9630299/" class="external text external">"NYPD officers to carry heroin antidote"</a>. <i>USA Today</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20140703123154/http://www.usatoday.com/story/news/nation-now/2014/05/27/new-york-police-department-naloxone/9630299/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140703123154/http://www.usatoday.com/story/news/nation-now/2014/05/27/new-york-police-department-naloxone/9630299/'" tppabs="https://web.archive.org/web/20140703123154/http://www.usatoday.com/story/news/nation-now/2014/05/27/new-york-police-department-naloxone/9630299/" class="external text external">Archived</a> from the original on 3 July 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">30 May</span> 2014</span>.</cite></span></li><li id="cite_note-100"> <span id="mw-reference-text-cite_note-100" class="mw-reference-text"><cite id="CITEREFFaulDaileySugermanSasser2015" class="citation journal cs1">Faul M, Dailey MW, Sugerman DE, Sasser SM, Levy B, Paulozzi LJ (2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455515  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455515'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455515" class="external text external">"Disparity in Naloxone Administration by Emergency Medical Service Providers and the Burden of Drug Overdose in US Rural Communities"</a>. <i>American Journal of Public Health</i>. <b>105</b>: e26–e32. doi:<a href="javascript:if(confirm('https://doi.org/10.2105%2FAJPH.2014.302520  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2105%2FAJPH.2014.302520'" tppabs="https://doi.org/10.2105%2FAJPH.2014.302520" class="external text external">10.2105/AJPH.2014.302520</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455515  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455515'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455515" class="external text external">4455515</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25905856  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25905856'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25905856" class="external text external">25905856</a>.</cite></span></li><li id="cite_note-101"> <span id="mw-reference-text-cite_note-101" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.ncsl.org/research/civil-and-criminal-justice/drug-overdose-immunity-good-samaritan-laws.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ncsl.org/research/civil-and-criminal-justice/drug-overdose-immunity-good-samaritan-laws.aspx'" tppabs="http://www.ncsl.org/research/civil-and-criminal-justice/drug-overdose-immunity-good-samaritan-laws.aspx" class="external text external">"Drug Overdose Immunity and Good Samaritan Laws"</a>. <i>www.ncsl.org</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-10-31</span></span>.</cite></span></li><li id="cite_note-cdc.gov-102"> <span id="mw-reference-text-cite_note-cdc.gov-102" class="mw-reference-text"><cite id="CITEREFCenters_for_Disease_Control_Prevention_(CDC)2010" class="citation journal cs1">Centers for Disease Control Prevention (CDC) (December 2010). <a href="javascript:if(confirm('https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6106a1.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6106a1.htm'" tppabs="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6106a1.htm" class="external text external">"Community-Based Opioid Overdose Prevention Programs Providing Naloxone — United States, 2010"</a>. <i>Centers for Disease Control and Prevention</i>. <b>61</b> (6): 101–5. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378715  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378715'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378715" class="external text external">4378715</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22337174  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22337174'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22337174" class="external text external">22337174</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20120426204807/http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6106a1.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120426204807/http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6106a1.htm'" tppabs="https://web.archive.org/web/20120426204807/http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6106a1.htm" class="external text external">Archived</a> from the original on 2012-04-26.</cite></span></li><li id="cite_note-103"> <span id="mw-reference-text-cite_note-103" class="mw-reference-text"><cite id="CITEREFKarissa_Donkin2012" class="citation web cs1">Karissa Donkin (9 September 2012). <a href="javascript:if(confirm('https://www.thestar.com/news/gta/2012/09/09/toronto_naloxone_program_reduces_drug_overdoses_among_addicts.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.thestar.com/news/gta/2012/09/09/toronto_naloxone_program_reduces_drug_overdoses_among_addicts.html'" tppabs="https://www.thestar.com/news/gta/2012/09/09/toronto_naloxone_program_reduces_drug_overdoses_among_addicts.html" class="external text external">"Toronto naloxone program reduces drug overdoses among addicts"</a>. <i>The Toronto Star</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20141205045540/http://www.thestar.com/news/gta/2012/09/09/toronto_naloxone_program_reduces_drug_overdoses_among_addicts.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20141205045540/http://www.thestar.com/news/gta/2012/09/09/toronto_naloxone_program_reduces_drug_overdoses_among_addicts.html'" tppabs="https://web.archive.org/web/20141205045540/http://www.thestar.com/news/gta/2012/09/09/toronto_naloxone_program_reduces_drug_overdoses_among_addicts.html" class="external text external">Archived</a> from the original on 5 December 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">5 May</span> 2015</span>.</cite></span></li><li id="cite_note-104"> <span id="mw-reference-text-cite_note-104" class="mw-reference-text"><cite id="CITEREFJonesComptonVythilingamGiroir2019" class="citation journal cs1">Jones, Christopher M.; Compton, Wilson; Vythilingam, Meena; Giroir, Brett (2019-08-06). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686765  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686765'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686765" class="external text external">"Naloxone Co-prescribing to Patients Receiving Prescription Opioids in the Medicare Part D Program, United States, 2016-2017"</a>. <i>JAMA</i>. <b>322</b> (5): 462–464. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.2019.7988  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.2019.7988'" tppabs="https://doi.org/10.1001%2Fjama.2019.7988" class="external text external">10.1001/jama.2019.7988</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0098-7484  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0098-7484'" tppabs="https://www.worldcat.org/issn/0098-7484" class="external text external">0098-7484</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686765  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686765'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686765" class="external text external">6686765</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31386124  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31386124'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31386124" class="external text external">31386124</a>.</cite></span></li><li id="cite_note-pmid21668761-105"> <span id="mw-reference-text-cite_note-pmid21668761-105" class="mw-reference-text"><cite id="CITEREFAlbertBrasonSanfordDasgupta2011" class="citation journal cs1">Albert S, Brason FW, Sanford CK, Dasgupta N, Graham J, Lovette B (June 2011). <a href="javascript:if(confirm('https://doi.org/10.1111/j.1526-4637.2011.01128.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111/j.1526-4637.2011.01128.x'" tppabs="https://doi.org/10.1111/j.1526-4637.2011.01128.x" class="external text external">"Project Lazarus: community-based overdose prevention in rural North Carolina"</a>. <i>Pain Med</i>. 12 Suppl 2: S77–85. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1526-4637.2011.01128.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1526-4637.2011.01128.x'" tppabs="https://doi.org/10.1111%2Fj.1526-4637.2011.01128.x" class="external text external">10.1111/j.1526-4637.2011.01128.x</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21668761  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21668761'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21668761" class="external text external">21668761</a>.</cite></span></li><li id="cite_note-Beletsky_2012-106"> <span id="mw-reference-text-cite_note-Beletsky_2012-106" class="mw-reference-text"><cite id="CITEREFBeletskyRichWalley2012" class="citation journal cs1">Beletsky L, Rich JD, Walley AY (November 2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551246  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551246'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551246" class="external text external">"Prevention of fatal opioid overdose"</a>. <i>JAMA</i>. <b>308</b> (18): 1863–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.2012.14205  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.2012.14205'" tppabs="https://doi.org/10.1001%2Fjama.2012.14205" class="external text external">10.1001/jama.2012.14205</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551246  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551246'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551246" class="external text external">3551246</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23150005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23150005'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23150005" class="external text external">23150005</a>.</cite></span></li><li id="cite_note-107"> <span id="mw-reference-text-cite_note-107" class="mw-reference-text"><cite id="CITEREFLavoie_D2012" class="citation journal cs1">Lavoie D (April 2012). <a href="javascript:if(confirm('https://www.huffingtonpost.com/2012/04/26/naloxone-drug-overdose-antidote_n_1456531.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.huffingtonpost.com/2012/04/26/naloxone-drug-overdose-antidote_n_1456531.html'" tppabs="https://www.huffingtonpost.com/2012/04/26/naloxone-drug-overdose-antidote_n_1456531.html" class="external text external">"Naloxone: Drug-Overdose Antidote Is Put In Addicts' Hands"</a>. <i>Huffington Post</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20120518161613/http://www.huffingtonpost.com/2012/04/26/naloxone-drug-overdose-antidote_n_1456531.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120518161613/http://www.huffingtonpost.com/2012/04/26/naloxone-drug-overdose-antidote_n_1456531.html'" tppabs="https://web.archive.org/web/20120518161613/http://www.huffingtonpost.com/2012/04/26/naloxone-drug-overdose-antidote_n_1456531.html" class="external text external">Archived</a> from the original on 2012-05-18.</cite></span></li><li id="cite_note-pmid19602236-108"> <span id="mw-reference-text-cite_note-pmid19602236-108" class="mw-reference-text"><cite id="CITEREFDavisBeletsky2009" class="citation journal cs1">Davis CS, Beletsky L (2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716314  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716314'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716314" class="external text external">"Bundling occupational safety with harm reduction information as a feasible method for improving police receptiveness to syringe access programs: evidence from three U.S. cities"</a>. <i>Harm Reduct J</i>. <b>6</b> (1): 16. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2F1477-7517-6-16  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2F1477-7517-6-16'" tppabs="https://doi.org/10.1186%2F1477-7517-6-16" class="external text external">10.1186/1477-7517-6-16</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716314  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716314'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716314" class="external text external">2716314</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19602236  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19602236'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19602236" class="external text external">19602236</a>.</cite></span></li><li id="cite_note-109"> <span id="mw-reference-text-cite_note-109" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.whitehouse.gov//sites/default/files/ondcp/policy-and-research/ndcs_2013.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.whitehouse.gov//sites/default/files/ondcp/policy-and-research/ndcs_2013.pdf'" tppabs="http://www.whitehouse.gov//sites/default/files/ondcp/policy-and-research/ndcs_2013.pdf" class="external text external">"2013 National drug control strategy"</a> <span class="cs1-format">(PDF)</span>. 2013. <a href="javascript:if(confirm('https://web.archive.org/web/20130506222525/http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/ndcs_2013.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20130506222525/http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/ndcs_2013.pdf'" tppabs="https://web.archive.org/web/20130506222525/http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/ndcs_2013.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 6 May 2013.</cite></span></li><li id="cite_note-110"> <span id="mw-reference-text-cite_note-110" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.ihra.net/files/2010/08/26/Danny_Morris.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ihra.net/files/2010/08/26/Danny_Morris.pdf'" tppabs="http://www.ihra.net/files/2010/08/26/Danny_Morris.pdf" class="external text external">"IHRA 21st International Conference Liverpool, 26th April 2010 - Introducing 'take home' Naloxone in Wales"</a> <span class="cs1-format">(PDF)</span>. <a href="javascript:if(confirm('https://web.archive.org/web/20110720062721/http://www.ihra.net/files/2010/08/26/Danny_Morris.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110720062721/http://www.ihra.net/files/2010/08/26/Danny_Morris.pdf'" tppabs="https://web.archive.org/web/20110720062721/http://www.ihra.net/files/2010/08/26/Danny_Morris.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 20 July 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">9 March</span> 2011</span>.</cite></span></li><li id="cite_note-cbc.ca-111"> <span id="mw-reference-text-cite_note-cbc.ca-111" class="mw-reference-text"><a href="javascript:if(confirm('http://www.cbc.ca/news/canada/calgary/naloxone-kits-fentanyl-overdose-province-1.3451860  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cbc.ca/news/canada/calgary/naloxone-kits-fentanyl-overdose-province-1.3451860'" tppabs="http://www.cbc.ca/news/canada/calgary/naloxone-kits-fentanyl-overdose-province-1.3451860" class="external text external">Naloxone kits now available at drug stores as province battles fentanyl crisis - Injection drug can temporarily reverse overdoses</a> <a href="javascript:if(confirm('https://web.archive.org/web/20160304141621/http://www.cbc.ca/news/canada/calgary/naloxone-kits-fentanyl-overdose-province-1.3451860  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160304141621/http://www.cbc.ca/news/canada/calgary/naloxone-kits-fentanyl-overdose-province-1.3451860'" tppabs="https://web.archive.org/web/20160304141621/http://www.cbc.ca/news/canada/calgary/naloxone-kits-fentanyl-overdose-province-1.3451860" class="external text external">Archived</a><span> 2016-03-04 at the </span>Wayback Machine. Retrieved 29 February 2016.</span></li><li id="cite_note-112"> <span id="mw-reference-text-cite_note-112" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://time.com/5432950/narcan-libraries-ymca/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://time.com/5432950/narcan-libraries-ymca/'" tppabs="http://time.com/5432950/narcan-libraries-ymca/" class="external text external">"Every U.S. Public Library and YMCA Will Soon Get Narcan for Free"</a>. <i>Time</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2 April</span> 2019</span>.</cite></span></li><li id="cite_note-113"> <span id="mw-reference-text-cite_note-113" class="mw-reference-text"><a href="javascript:if(confirm('http://reach4me.org/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://reach4me.org/'" tppabs="http://reach4me.org/" class="external text external">Reach for Me: Fighting to End the American Drug Overdose Epidemic</a> <a href="javascript:if(confirm('https://web.archive.org/web/20141217004049/http://reach4me.org/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20141217004049/http://reach4me.org/'" tppabs="https://web.archive.org/web/20141217004049/http://reach4me.org/" class="external text external">Archived</a><span> 2014-12-17 at the </span>Wayback Machine</span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/rn/465-65-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/rn/465-65-6'" tppabs="https://druginfo.nlm.nih.gov/drugportal/rn/465-65-6" class="external text external">"Naloxone"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li>
<li><a href="javascript:if(confirm('http://www.inchem.org/documents/antidote/antidote/ant01.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.inchem.org/documents/antidote/antidote/ant01.htm'" tppabs="http://www.inchem.org/documents/antidote/antidote/ant01.htm" class="external text external">Report on Naloxone and other opiate antidotes</a>, by the International Programme on Chemical Safety</li>
<li><a href="javascript:if(confirm('https://www.samhsa.gov/medication-assisted-treatment/treatment/naloxone  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.samhsa.gov/medication-assisted-treatment/treatment/naloxone'" tppabs="https://www.samhsa.gov/medication-assisted-treatment/treatment/naloxone" class="external text external">What Is Naloxone? via Substance Abuse and Mental Health Services Administration| SAMHSA</a></li>
<li><a href="javascript:if(confirm('http://www.pdaps.org/datasets/laws-regulating-administration-of-naloxone-1501695139  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pdaps.org/datasets/laws-regulating-administration-of-naloxone-1501695139'" tppabs="http://www.pdaps.org/datasets/laws-regulating-administration-of-naloxone-1501695139" class="external text external">Naloxone Overdose Prevention Laws | PDAPS.org</a></li>
<li><cite class="citation web cs1"><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a616003.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a616003.html'" tppabs="https://medlineplus.gov/druginfo/meds/a616003.html" class="external text external">"Naloxone Nasal Spray"</a>. <i>MedlinePlus</i>.</cite></li>
<li><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/drugs/drug-safety-and-availability/fda-recommends-health-care-professionals-discuss-naloxone-all-patients-when-prescribing-opioid-pain  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/drugs/drug-safety-and-availability/fda-recommends-health-care-professionals-discuss-naloxone-all-patients-when-prescribing-opioid-pain'" tppabs="https://www.fda.gov/drugs/drug-safety-and-availability/fda-recommends-health-care-professionals-discuss-naloxone-all-patients-when-prescribing-opioid-pain" class="external text external">"FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder"</a>. <i>U.S. Food and Drug Administration (FDA)</i>. 23 July 2020.</cite>&lt;/ref&gt;</li></ul>

<div role="navigation" class="navbox" aria-labelledby="Antidotes_(V03AB)" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antidotes_(V03AB)" style="font-size:114%;margin:0 4em">Antidotes (V03AB)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Nervous<br> system</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Alcohol intoxication</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Metadoxine, <a href="Thiamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiamine" title="Thiamine">Thiamine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Barbiturate<br> overdose</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Bemegride.htm" tppabs="https://ptable.com/wiki/compounds/A/Bemegride" title="Bemegride">Bemegride</a></li>
<li><a href="Etamivan.htm" tppabs="https://ptable.com/wiki/compounds/A/Etamivan" title="Etamivan">Ethamivan</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Benzodiazepine<br> overdose</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cyprodenate</li>
<li><a href="Flumazenil.htm" tppabs="https://ptable.com/wiki/compounds/A/Flumazenil" title="Flumazenil">Flumazenil</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">GHB overdose</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Physostigmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Physostigmine" title="Physostigmine">Physostigmine</a></li>
<li>SCH-50911</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Nerve agent /<br> Organophosphate<br> poisoning</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Atropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atropine" title="Atropine">Atropine</a><sup>#</sup></li>
<li><a href="Biperiden.htm" tppabs="https://ptable.com/wiki/compounds/A/Biperiden" title="Biperiden">Biperiden</a></li>
<li><a href="Diazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Diazepam" title="Diazepam">Diazepam</a><sup>#</sup></li>
<li><a href="Oxime.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxime" title="Oxime">Oximes</a>
<ul><li><a href="Obidoxime.htm" tppabs="https://ptable.com/wiki/compounds/A/Obidoxime" title="Obidoxime">Obidoxime</a></li>
<li><a href="Pralidoxime.htm" tppabs="https://ptable.com/wiki/compounds/A/Pralidoxime" title="Pralidoxime">Pralidoxime</a></li></ul></li>
<li><i>see also:</i> Cholinesterase</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Opioid overdose</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Diprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diprenorphine" title="Diprenorphine">Diprenorphine</a></li>
<li><a href="Doxapram.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxapram" title="Doxapram">Doxapram</a></li>
<li><a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a></li>
<li><a href="Nalorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalorphine" title="Nalorphine">Nalorphine</a></li>
<li><a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a><sup>#</sup></li>
<li><a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">Naltrexone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Reversal of<br> neuromuscular blockade</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Sugammadex</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Circulatory<br> system</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Beta blocker</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Glucagon.htm" tppabs="https://ptable.com/wiki/compounds/A/Glucagon" title="Glucagon">Glucagon</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Digoxin toxicity</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Digoxin immune fab</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Anticoagulants</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>against direct Xa inhibitors (Andexanet alfa)</li>
<li>against <a href="Heparin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heparin" title="Heparin">heparin</a> (Protamine<sup>#</sup>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Arsenic poisoning</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Dimercaprol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimercaprol" title="Dimercaprol">Dimercaprol</a><sup>#</sup></li>
<li><a href="Dimercaptosuccinic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimercaptosuccinic_acid" title="Dimercaptosuccinic acid">Succimer</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Cyanide poisoning</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>4-Dimethylaminophenol</li>
<li><a href="Hydroxocobalamin.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxocobalamin" title="Hydroxocobalamin">Hydroxocobalamin</a></li>
<li><i><a href="Nitrite.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrite" title="Nitrite">nitrite</a></i>
<ul><li><a href="Amyl_nitrite.htm" tppabs="https://ptable.com/wiki/compounds/A/Amyl_nitrite" title="Amyl nitrite">Amyl nitrite</a></li>
<li><a href="Sodium_nitrite.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_nitrite" title="Sodium nitrite">Sodium nitrite</a><sup>#</sup></li></ul></li>
<li><a href="Sodium_thiosulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_thiosulfate" title="Sodium thiosulfate">Sodium thiosulfate</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Hydrofluoric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrofluoric_acid" title="Hydrofluoric acid">Hydrofluoric acid</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Calcium_gluconate.htm" tppabs="https://ptable.com/wiki/compounds/A/Calcium_gluconate" title="Calcium gluconate">Calcium gluconate</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Methanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Methanol" title="Methanol">Methanol</a> /<br> Ethylene glycol<br> poisoning</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Primary alcohols: Ethanol</li>
<li><a href="Fomepizole.htm" tppabs="https://ptable.com/wiki/compounds/A/Fomepizole" title="Fomepizole">Fomepizole</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Paracetamol toxicity<br> (Acetaminophen)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Acetylcysteine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetylcysteine" title="Acetylcysteine">Acetylcysteine</a><sup>#</sup></li>
<li><a href="Glutathione.htm" tppabs="https://ptable.com/wiki/compounds/A/Glutathione" title="Glutathione">Glutathione</a></li>
<li><a href="Methionine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methionine" title="Methionine">Methionine</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Toxic metals (cadmium
<ul><li>lead</li>
<li>mercury</li>
<li>thallium)</li></ul></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Dimercaprol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimercaprol" title="Dimercaprol">Dimercaprol</a><sup>#</sup></li>
<li><a href="Ethylenediaminetetraacetic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylenediaminetetraacetic_acid" title="Ethylenediaminetetraacetic acid">Edetates</a></li>
<li><a href="Prussian_blue.htm" tppabs="https://ptable.com/wiki/compounds/A/Prussian_blue" title="Prussian blue">Prussian blue</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>iodine-131</i>
<ul><li><a href="Potassium_iodide.htm" tppabs="https://ptable.com/wiki/compounds/A/Potassium_iodide" title="Potassium iodide">Potassium iodide</a></li></ul></li>
<li>Methylthioninium chloride<sup>#</sup></li>
<li><i>oxidizing agent</i>
<ul><li><a href="Potassium_permanganate.htm" tppabs="https://ptable.com/wiki/compounds/A/Potassium_permanganate" title="Potassium permanganate">Potassium permanganate</a></li></ul></li>
<li>Prednisolone/promethazine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Emetic</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Copper(II)_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Copper(II)_sulfate" title="Copper(II) sulfate">Copper sulfate</a></li>
<li>Ipecacuanha
<ul><li>Syrup of ipecac</li></ul></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Opioid_receptor_modulators" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Opioid_receptor_modulators" style="font-size:114%;margin:0 4em">Opioid receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>MOR</abbr></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists (abridged; see here for a full list):</i> 3-HO-PCP</li>
<li><span class="new">7-Acetoxymitragynine</span></li>
<li>7-Hydroxymitragynine</li>
<li><span class="new">ψ-Akuammigine</span></li>
<li>α-Chlornaltrexamine</li>
<li><span class="new">α-Narcotine</span></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Acetyldihydrocodeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Acetyldihydrocodeine'" tppabs="https://ptable.com/wiki/compounds/A/Acetyldihydrocodeine" title="Acetyldihydrocodeine">Acetyldihydrocodeine</a></li>
<li>Acetylfentanyl</li>
<li>Acrylfentanyl</li>
<li>Adrenorphin (metorphamide)</li>
<li>AH-7921</li>
<li>Akuammicine</li>
<li><span class="new">Akuammidine</span></li>
<li><a href="Alfentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Alfentanil" title="Alfentanil">Alfentanil</a></li>
<li><a href="Anileridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Anileridine" title="Anileridine">Anileridine</a></li>
<li>Apparicine</li>
<li>β-Endorphin</li>
<li><span class="new">BAM-12P</span></li>
<li><span class="new">BAM-18P</span></li>
<li><span class="new">BAM-22P</span></li>
<li>Benzhydrocodone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Benzylmorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Benzylmorphine'" tppabs="https://ptable.com/wiki/compounds/A/Benzylmorphine" title="Benzylmorphine">Benzylmorphine</a></li>
<li><a href="Bezitramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bezitramide" title="Bezitramide">Bezitramide</a></li>
<li>Biphalin</li>
<li><span class="new">BU08070</span></li>
<li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphan" title="Butorphan" class="mw-redirect">Butorphan</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphanol" title="Butorphanol">Butorphanol</a></li>
<li>Butyrfentanyl</li>
<li>BW373U86</li>
<li><a href="Carfentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Carfentanil" title="Carfentanil">Carfentanil</a></li>
<li>Casokefamide</li>
<li>Cebranopadol</li>
<li>Chloroxymorphamine</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">Codeine</a></li>
<li>DADLE</li>
<li>DAMGO (DAGO)</li>
<li>Dermorphin</li>
<li>Desmetramadol (desmethyltramadol)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Desomorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Desomorphine'" tppabs="https://ptable.com/wiki/compounds/A/Desomorphine" title="Desomorphine">Desomorphine</a></li>
<li><a href="Dextromoramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromoramide" title="Dextromoramide">Dextromoramide</a></li>
<li><a href="Dextropropoxyphene.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextropropoxyphene" title="Dextropropoxyphene">Dextropropoxyphene (propoxyphene)</a></li>
<li><a href="Dezocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dezocine" title="Dezocine">Dezocine</a></li>
<li><a href="Dimenoxadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimenoxadol" title="Dimenoxadol">Dimenoxadol</a></li>
<li>Dimethylaminopivalophenone</li>
<li>Eluxadoline</li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine (heroin)</a></li>
<li><a href="Dihydrocodeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrocodeine" title="Dihydrocodeine">Dihydrocodeine</a></li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Dihydromorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydromorphine" title="Dihydromorphine">Dihydromorphine</a></li>
<li>Dinalbuphine sebacate</li>
<li><a href="Diphenoxylate.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenoxylate" title="Diphenoxylate">Diphenoxylate</a></li>
<li><a href="Dipipanone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dipipanone" title="Dipipanone">Dipipanone</a></li>
<li>Dynorphin A</li>
<li><a href="Embutramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Embutramide" title="Embutramide">Embutramide</a></li>
<li>Endomorphin-1</li>
<li>Endomorphin-2</li>
<li>Eseroline</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Ethylmorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Ethylmorphine'" tppabs="https://ptable.com/wiki/compounds/A/Ethylmorphine" title="Ethylmorphine">Ethylmorphine</a></li>
<li><a href="Etorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Etorphine" title="Etorphine">Etorphine</a></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li>Fluorophen</li>
<li>Frakefamide</li>
<li>Furanylfentanyl</li>
<li>Hemorphin-4</li>
<li>Herkinorin</li>
<li>Hodgkinsine</li>
<li><a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">Hydrocodone</a></li>
<li><a href="Hydromorphinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphinol" title="Hydromorphinol">Hydromorphinol</a></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a></li>
<li>IBNtxA</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>Ketobemidone</li>
<li>Kratom</li>
<li><a href="Laudanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Laudanosine" title="Laudanosine">Laudanosine</a></li>
<li>Lefetamine</li>
<li>Leu-enkephalin</li>
<li><a href="Levacetylmethadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levacetylmethadol" title="Levacetylmethadol">Levacetylmethadol</a></li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><span class="new">Lexanopadol</span></li>
<li><a href="Loperamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Loperamide" title="Loperamide">Loperamide</a></li>
<li><span class="new">Loxicodegol</span></li>
<li>Matrine</li>
<li>Meptazinol</li>
<li>Met-enkephalin (metenkefalin)</li>
<li><a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">Methadone</a></li>
<li>Metkefamide</li>
<li>Metopon</li>
<li>Mitragynine</li>
<li>Mitragynine pseudoindoxyl</li>
<li>Morphiceptin</li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a></li>
<li><a href="Nalbuphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalbuphine" title="Nalbuphine">Nalbuphine</a></li>
<li><span class="new">NalBzOH</span></li>
<li>Nalmexone</li>
<li>Naltalimide</li>
<li><span class="new">Neopine</span></li>
<li>NFEPP</li>
<li>Nicocodeine</li>
<li>Nicodicodine</li>
<li>Nicomorphine</li>
<li><span class="new">NKTR-181</span></li>
<li>Norketamine</li>
<li><a href="Octreotide.htm" tppabs="https://ptable.com/wiki/compounds/A/Octreotide" title="Octreotide">Octreotide</a></li>
<li>Oliceridine</li>
<li>OM-3-MNZ</li>
<li><a href="Oripavine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oripavine" title="Oripavine">Oripavine</a></li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a></li>
<li>Oxymorphazone</li>
<li><span class="new">Oxymorphonazine</span></li>
<li><a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">Oxymorphone</a></li>
<li><span class="new">Oxymorphone phenylhydrazone</span></li>
<li><span class="new">OxyPNPH</span></li>
<li><i>Papaver somniferum</i> (opium)</li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li>Pericine</li>
<li><a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">Pethidine (meperidine)</a></li>
<li>Phenazocine</li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li>
<li>Piminodine</li>
<li>Piritramide</li>
<li><span class="new">PL-017</span></li>
<li><a href="Prodine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prodine" title="Prodine">Prodine</a></li>
<li>Propiram</li>
<li>PZM21</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Racemethorphan</a></li>
<li>Racemorphan</li>
<li><a href="Remifentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Remifentanil" title="Remifentanil">Remifentanil</a></li>
<li><span class="new">Salsolinol</span></li>
<li>SC-17599</li>
<li><a href="Sinomenine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sinomenine" title="Sinomenine">Sinomenine</a></li>
<li><a href="Sufentanil.htm" tppabs="https://ptable.com/wiki/compounds/A/Sufentanil" title="Sufentanil">Sufentanil</a></li>
<li>Tapentadol</li>
<li>Tetrahydropapaveroline</li>
<li><span class="new">TH-030418</span></li>
<li><a href="Thebaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thebaine" title="Thebaine">Thebaine</a></li>
<li>Thienorphine</li>
<li>Tianeptine</li>
<li>Tilidine</li>
<li><a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">Tramadol</a></li>
<li>Trimebutine</li>
<li>TRIMU 5</li>
<li><span class="new">TRV734</span></li>
<li><span class="new">Tubotaiwine</span></li>
<li>U-47700</li>
<li>Valorphin</li>
<li>Viminol</li>
<li>Xorphanol</li></ul>

<ul><li><i>PAMs:</i> <span class="new">BMS-986121</span></li>
<li><span class="new">BMS-986122</span></li></ul>

<ul><li><i>Antagonists:</i> (3S,4S)-Picenadol</li>
<li>2-(S)-N,N-(R)-Viminol</li>
<li><span class="new">3CS-nalmefene</span></li>
<li>4-Caffeoyl-1,5-quinide</li>
<li><span class="new">4′-Hydroxyflavanone</span></li>
<li>4',7-Dihydroxyflavone</li>
<li>6β-Naltrexol</li>
<li>6β-Naltrexol-d4</li>
<li>18-MC</li>
<li><span class="new">α-Gliadin</span></li>
<li>β-Chlornaltrexamine</li>
<li>β-Funaltrexamine</li>
<li>Akuammine</li>
<li><a href="Alvimopan.htm" tppabs="https://ptable.com/wiki/compounds/A/Alvimopan" title="Alvimopan">Alvimopan</a></li>
<li>AM-251</li>
<li><a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">Apigenin</a></li>
<li>AT-076</li>
<li>Axelopran</li>
<li>Bevenopran</li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Catechin" title="Catechin">Catechin</a></li>
<li>Catechin gallate</li>
<li>Clocinnamox</li>
<li>CTAP</li>
<li><span class="new">CTOP</span></li>
<li><span class="new">Cyclofoxy</span></li>
<li>Cyprodime</li>
<li>Diacetylnalorphine</li>
<li><a href="Diprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diprenorphine" title="Diprenorphine">Diprenorphine</a></li>
<li>ECG</li>
<li><a href="Gallocatechol.htm" tppabs="https://ptable.com/wiki/compounds/A/Gallocatechol" title="Gallocatechol">EGC</a></li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epicatechin" title="Epicatechin" class="mw-redirect">Epicatechin</a></li>
<li>Eptazocine</li>
<li>Gemazocine</li>
<li><span class="new">Ginsenoside R</span></li>
<li>Hyperoside</li>
<li>Ibogaine</li>
<li><a href="Levallorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Levallorphan" title="Levallorphan">Levallorphan</a></li>
<li>Lobeline</li>
<li>LY-255582</li>
<li><span class="new">LY-2196044</span></li>
<li><span class="new">Methocinnamox</span></li>
<li>Methylnaltrexone</li>
<li><span class="new">Methylsamidorphan chloride</span></li>
<li>Naldemedine</li>
<li><a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a></li>
<li>Nalodeine (N-allylnorcodeine)</li>
<li><a href="Nalorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalorphine" title="Nalorphine">Nalorphine</a></li>
<li>Nalorphine dinicotinate</li>
<li>Naloxazone</li>
<li>Naloxegol</li>
<li>Naloxol</li>
<li>Naloxonazine</li>
<li><a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a></li>
<li><span class="new">Naltrexazone</span></li>
<li><span class="new">Naltrexonazine</span></li>
<li><a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">Naltrexone</a></li>
<li>Naltrindole</li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li>Noribogaine</li>
<li>Oxilorphan</li>
<li>Pawhuskin A</li>
<li><a href="Rimonabant.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimonabant" title="Rimonabant">Rimonabant</a></li>
<li>Quadazocine</li>
<li>Samidorphan</li>
<li>Taxifolin</li></ul>

<ul><li><i>Unknown/unsorted:</i> <a href="Cannabidiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cannabidiol" title="Cannabidiol">Cannabidiol</a></li>
<li>Coronaridine</li>
<li>Cyproterone acetate</li>
<li><span class="new">Dihydroakuuamine</span></li>
<li>Tabernanthine</li>
<li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">Tetrahydrocannabinol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>DOR</abbr></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">3CS-nalmefene</span></li>
<li>6'-GNTI</li>
<li>7-SIOM</li>
<li><span class="new">ADL-5747 (PF-04856881)</span></li>
<li><span class="new">ADL-5859</span></li>
<li>Alazocine (SKF-10047)</li>
<li><a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">Amoxapine</a></li>
<li><span class="new">AR-M100390 (ARM390)</span></li>
<li><span class="new">AZD2327</span></li>
<li>β-Endorphin</li>
<li><span class="new">BAM-18P</span></li>
<li>Biphalin</li>
<li>BU-48</li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphan" title="Butorphan" class="mw-redirect">Butorphan</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphanol" title="Butorphanol">Butorphanol</a></li>
<li>BW373U86</li>
<li>Casokefamide</li>
<li>Cebranopadol</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">Codeine</a></li>
<li><a href="Cyclazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclazocine" title="Cyclazocine">Cyclazocine</a></li>
<li>DADLE</li>
<li>Deltorphin A</li>
<li>Deltorphin I</li>
<li><span class="new">Deltorphin II</span></li>
<li>Desmethylclozapine</li>
<li>Desmetramadol (desmethyltramadol)</li>
<li><a href="Dezocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dezocine" title="Dezocine">Dezocine</a></li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine (heroin)</a></li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Dihydromorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydromorphine" title="Dihydromorphine">Dihydromorphine</a></li>
<li>DPDPE</li>
<li>DPI-221</li>
<li>DPI-3290</li>
<li><span class="new">DSLET</span></li>
<li>Ethylketazocine</li>
<li><a href="Etorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Etorphine" title="Etorphine">Etorphine</a></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li><span class="new">FIT</span></li>
<li>Fluorophen</li>
<li>Hemorphin-4</li>
<li><a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">Hydrocodone</a></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a></li>
<li>Ibogaine</li>
<li>Isomethadone</li>
<li><span class="new">JNJ-20788560</span></li>
<li><span class="new">KNT-127</span></li>
<li>Kratom</li>
<li><a href="Laudanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Laudanosine" title="Laudanosine">Laudanosine</a></li>
<li>Leu-enkephalin</li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><span class="new">Lexanopadol</span></li>
<li>Lofentanil</li>
<li>Met-enkephalin (metenkefalin)</li>
<li>Metazocine</li>
<li>Metkefamide</li>
<li>Mitragynine</li>
<li>Mitragynine pseudoindoxyl</li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a></li>
<li>N-Phenethyl-14-ethoxymetopon</li>
<li>Norbuprenorphine</li>
<li><span class="new">NalBzOH</span></li>
<li><a href="Oripavine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oripavine" title="Oripavine">Oripavine</a></li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a></li>
<li><a href="Oxymorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymorphone" title="Oxymorphone">Oxymorphone</a></li>
<li><a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">Pethidine (meperidine)</a></li>
<li>Proglumide</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Racemethorphan</a></li>
<li>Racemorphan</li>
<li>RWJ-394674</li>
<li>Samidorphan</li>
<li><span class="new">SB-235863</span></li>
<li>SNC-80</li>
<li><span class="new">SNC-162</span></li>
<li>TAN-67 (SB-205,607)</li>
<li><span class="new">TH-030418</span></li>
<li><a href="Thebaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thebaine" title="Thebaine">Thebaine</a></li>
<li>Thiobromadol (C-8813)</li>
<li>Tonazocine</li>
<li><a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">Tramadol</a></li>
<li><span class="new">TRV250</span></li>
<li>Xorphanol</li>
<li>Zenazocine</li></ul>

<ul><li><i>Antagonists:</i> 4',7-Dihydroxyflavone</li>
<li><span class="new">5'-NTII</span></li>
<li>6β-Naltrexol</li>
<li>6β-Naltrexol-d4</li>
<li><span class="new">α-Santolol</span></li>
<li>β-Chlornaltrexamine</li>
<li><a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">Apigenin</a></li>
<li>AT-076</li>
<li>Axelopran</li>
<li>Bevenopran</li>
<li><span class="new">BNTX</span></li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Catechin" title="Catechin">Catechin</a></li>
<li>Catechin gallate</li>
<li>Clocinnamox</li>
<li>Diacetylnalorphine</li>
<li><a href="Diprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diprenorphine" title="Diprenorphine">Diprenorphine</a></li>
<li>ECG</li>
<li><a href="Gallocatechol.htm" tppabs="https://ptable.com/wiki/compounds/A/Gallocatechol" title="Gallocatechol">EGC</a></li>
<li>Eluxadoline</li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epicatechin" title="Epicatechin" class="mw-redirect">Epicatechin</a></li>
<li><span class="new">ICI-154129</span></li>
<li><span class="new">ICI-174864</span></li>
<li>LY-255582</li>
<li><span class="new">LY-2196044</span></li>
<li>Methylnaltrexone</li>
<li><span class="new">Methylnaltrindole</span></li>
<li><span class="new">N-Benzylnaltrindole</span></li>
<li><a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a></li>
<li><a href="Nalorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalorphine" title="Nalorphine">Nalorphine</a></li>
<li><a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">Naltrexone</a></li>
<li>Naltriben</li>
<li>Naltrindole</li>
<li><a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a></li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li>Noribogaine</li>
<li>Pawhuskin A</li>
<li>Quadazocine</li>
<li><span class="new">SDM25N</span></li>
<li>SoRI-9409</li>
<li>Taxifolin</li>
<li>Thienorphine</li></ul>

<ul><li><i>Unknown/unsorted:</i> 18-MC</li>
<li><a href="Cannabidiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cannabidiol" title="Cannabidiol">Cannabidiol</a></li>
<li>Coronaridine</li>
<li>Cyproterone acetate</li>
<li>Tabernanthine</li>
<li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">Tetrahydrocannabinol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>KOR</abbr></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">3CS-nalmefene</span></li>
<li>6'-GNTI</li>
<li>8-CAC</li>
<li>18-MC</li>
<li>14-Methoxymetopon</li>
<li>β-Chlornaltrexamine</li>
<li>β-Funaltrexamine</li>
<li>Adrenorphin (metorphamide)</li>
<li><span class="new">Akuuamicine</span></li>
<li>Alazocine (SKF-10047)</li>
<li><span class="new">Allomatrine</span></li>
<li><span class="new">Apadoline</span></li>
<li>Asimadoline</li>
<li><span class="new">BAM-12P</span></li>
<li><span class="new">BAM-18P</span></li>
<li><span class="new">BAM-22P</span></li>
<li>Big dynorphin</li>
<li>Bremazocine</li>
<li>BRL-52537</li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphan" title="Butorphan" class="mw-redirect">Butorphan</a></li>
<li><a href="Butorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Butorphanol" title="Butorphanol">Butorphanol</a></li>
<li>BW373U86</li>
<li>Cebranopadol</li>
<li>Ciprefadol</li>
<li>CR665</li>
<li><a href="Cyclazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclazocine" title="Cyclazocine">Cyclazocine</a></li>
<li>Cyclorphan</li>
<li><a href="Cyprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyprenorphine" title="Cyprenorphine">Cyprenorphine</a></li>
<li>Desmetramadol (desmethyltramadol)</li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine (heroin)</a></li>
<li>Diacetylnalorphine</li>
<li>Difelikefalin</li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Dihydromorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydromorphine" title="Dihydromorphine">Dihydromorphine</a></li>
<li>Dinalbuphine sebacate</li>
<li><a href="Diprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diprenorphine" title="Diprenorphine">Diprenorphine</a></li>
<li>Dynorphin A</li>
<li>Dynorphin B (rimorphin)</li>
<li>Eluxadoline</li>
<li>Enadoline</li>
<li>Eptazocine</li>
<li><span class="new">Erinacine E</span></li>
<li>Ethylketazocine</li>
<li><a href="Etorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Etorphine" title="Etorphine">Etorphine</a></li>
<li>Fedotozine</li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li>Gemazocine</li>
<li>GR-89696</li>
<li><span class="new">GR-103545</span></li>
<li>Hemorphin-4</li>
<li>Herkinorin</li>
<li><span class="new">HS665</span></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a></li>
<li>HZ-2</li>
<li>Ibogaine</li>
<li>ICI-199,441</li>
<li>ICI-204,448</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>Ketazocine</li>
<li><a href="Laudanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Laudanosine" title="Laudanosine">Laudanosine</a></li>
<li>Leumorphin (dynorphin B-29)</li>
<li><a href="Levallorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Levallorphan" title="Levallorphan">Levallorphan</a></li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><span class="new">Lexanopadol</span></li>
<li>Lofentanil</li>
<li>LPK-26</li>
<li>Lufuradom</li>
<li>Matrine</li>
<li><span class="new">MB-1C-OH</span></li>
<li><a href="Menthol.htm" tppabs="https://ptable.com/wiki/compounds/A/Menthol" title="Menthol">Menthol</a></li>
<li>Metazocine</li>
<li>Metkefamide</li>
<li><a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">Mianserin</a></li>
<li><a href="Mirtazapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mirtazapine" title="Mirtazapine">Mirtazapine</a></li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a></li>
<li>Moxazocine</li>
<li><span class="new">MR-2034</span></li>
<li><span class="new">N-MPPP</span></li>
<li><a href="Nalbuphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalbuphine" title="Nalbuphine">Nalbuphine</a></li>
<li><span class="new">NalBzOH</span></li>
<li>Nalfurafine</li>
<li><a href="Nalmefene.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalmefene" title="Nalmefene">Nalmefene</a></li>
<li>Nalodeine (N-allylnorcodeine)</li>
<li><a href="Nalorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nalorphine" title="Nalorphine">Nalorphine</a></li>
<li>Naltriben</li>
<li>Niravoline</li>
<li>Norbuprenorphine</li>
<li>Norbuprenorphine-3-glucuronide</li>
<li>Noribogaine</li>
<li>Norketamine</li>
<li><a href="Oripavine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oripavine" title="Oripavine">Oripavine</a></li>
<li>Oxilorphan</li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a></li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li><a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">Pethidine (meperidine)</a></li>
<li>Phenazocine</li>
<li>Proxorphan</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Racemethorphan</a></li>
<li>Racemorphan</li>
<li>RB-64</li>
<li><a href="Salvinorin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvinorin_A" title="Salvinorin A">Salvinorin A</a> (<a href="Salvia_divinorum.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvia_divinorum" title="Salvia divinorum">salvia</a>)</li>
<li>Salvinorin B ethoxymethyl ether</li>
<li>Salvinorin B methoxymethyl ether</li>
<li>Samidorphan</li>
<li>Spiradoline (U-62,066)</li>
<li><span class="new">TH-030418</span></li>
<li>Thienorphine</li>
<li>Tifluadom</li>
<li>Tricyclic antidepressants (e.g., <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">amitriptyline</a>, desipramine, <a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">imipramine</a>, <a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">nortriptyline</a>)</li>
<li>U-50488</li>
<li><span class="new">U-54,494A</span></li>
<li>U-69,593</li>
<li>Xorphanol</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">4′-Hydroxyflavanone</span></li>
<li>4',7-Dihydroxyflavone</li>
<li>5'-GNTI</li>
<li>6'-GNTI</li>
<li>6β-Naltrexol</li>
<li>6β-Naltrexol-d4</li>
<li>β-Chlornaltrexamine</li>
<li>Buprenorphine/samidorphan</li>
<li><a href="Amentoflavone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amentoflavone" title="Amentoflavone">Amentoflavone</a></li>
<li><span class="new">ANTI</span></li>
<li><a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">Apigenin</a></li>
<li><span class="new">Arodyne</span></li>
<li>AT-076</li>
<li>Aticaprant</li>
<li>Axelopran</li>
<li><span class="new">AZ-MTAB</span></li>
<li>Binaltorphimine</li>
<li>BU09059</li>
<li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a></li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Catechin" title="Catechin">Catechin</a></li>
<li>Catechin gallate</li>
<li>CERC-501 (LY-2456302)</li>
<li>Clocinnamox</li>
<li><span class="new">Cyclofoxy</span></li>
<li><a href="Dezocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dezocine" title="Dezocine">Dezocine</a></li>
<li><span class="new">DIPPA</span></li>
<li><a href="Gallocatechol.htm" tppabs="https://ptable.com/wiki/compounds/A/Gallocatechol" title="Gallocatechol">EGC</a></li>
<li>ECG</li>
<li><a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epicatechin" title="Epicatechin" class="mw-redirect">Epicatechin</a></li>
<li>Hyperoside</li>
<li>JDTic</li>
<li>LY-255582</li>
<li><span class="new">LY-2196044</span></li>
<li><span class="new">LY-2444296</span></li>
<li>LY-2459989</li>
<li><span class="new">LY-2795050</span></li>
<li><span class="new">MeJDTic</span></li>
<li>Methylnaltrexone</li>
<li><span class="new">ML190</span></li>
<li><span class="new">ML350</span></li>
<li><span class="new">MR-2266</span></li>
<li><span class="new">N-Fluoropropyl-JDTic</span></li>
<li><a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a></li>
<li><a href="Naltrexone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naltrexone" title="Naltrexone">Naltrexone</a></li>
<li>Naltrindole</li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li>Norbinaltorphimine</li>
<li>Noribogaine</li>
<li>Pawhuskin A</li>
<li>PF-4455242</li>
<li>RB-64</li>
<li>Quadazocine</li>
<li>Taxifolin</li>
<li><span class="new">UPHIT</span></li>
<li>Zyklophin</li></ul>

<ul><li><i>Unknown/unsorted:</i> Akuammicine</li>
<li>Akuammine</li>
<li>Coronaridine</li>
<li>Cyproterone acetate</li>
<li><span class="new">Dihydroakuuamine</span></li>
<li>Ibogamine</li>
<li>Tabernanthine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>NOP</abbr></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">(Arg14,Lys15)Nociceptin</span></li>
<li><span class="new">((pF)Phe<sup>4</sup>)Nociceptin(1-13)NH<sub>2</sub></span></li>
<li><span class="new">(Phe<sup>1</sup>Ψ(CH<sub>2</sub>-NH)Gly<sup>2</sup>)Nociceptin(1-13)NH<sub>2</sub></span></li>
<li><span class="new">Ac-RYYRWK-NH<sub>2</sub></span></li>
<li><span class="new">Ac-RYYRIK-NH<sub>2</sub></span></li>
<li><span class="new">BU08070</span></li>
<li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a></li>
<li>Cebranopadol</li>
<li><a href="Dihydroetorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a></li>
<li><a href="Etorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Etorphine" title="Etorphine">Etorphine</a></li>
<li><span class="new">JNJ-19385899</span></li>
<li>Levomethorphan</li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">Levorphanol</a></li>
<li><span class="new">Lexanopadol</span></li>
<li>MCOPPB</li>
<li><span class="new">MT-7716</span></li>
<li>NNC 63-0532</li>
<li>Nociceptin (orphanin FQ)</li>
<li><span class="new">Nociceptin (1-11)</span></li>
<li><span class="new">Nociceptin (1-13)NH<sub>2</sub></span></li>
<li>Norbuprenorphine</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Racemethorphan</a></li>
<li>Racemorphan</li>
<li>Ro64-6198</li>
<li><span class="new">Ro65-6570</span></li>
<li><span class="new">SCH-221510</span></li>
<li><span class="new">SCH-486757</span></li>
<li><span class="new">SR-8993</span></li>
<li><span class="new">SR-16435</span></li>
<li><span class="new">TH-030418</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">(Nphe<sup>1</sup>)Nociceptin(1-13)NH<sub>2</sub></span></li>
<li>AT-076</li>
<li><span class="new">BAN-ORL-24</span></li>
<li>BTRX-246040 (LY-2940094)</li>
<li>J-113,397</li>
<li>JTC-801</li>
<li><span class="new">NalBzOH</span></li>
<li><span class="new">Nociceptin (1-7)</span></li>
<li><span class="new">Nocistatin</span></li>
<li>SB-612,111</li>
<li><span class="new">SR-16430</span></li>
<li>Thienorphine</li>
<li><span class="new">Trap-101</span></li>
<li><span class="new">UFP-101</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Unsorted</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>β-Casomorphins</li>
<li>Amidorphin</li>
<li><span class="new">BAM-20P</span></li>
<li>Cytochrophin-4</li>
<li><span class="new">Deprolorphin</span></li>
<li>Gliadorphin (gluteomorphin)</li>
<li>Gluten exorphins</li>
<li>Hemorphins</li>
<li><a href="Kava.htm" tppabs="https://ptable.com/wiki/compounds/A/Kava" title="Kava">Kava</a> constituents</li>
<li><span class="new">MEAGL</span></li>
<li><span class="new">MEAP</span></li>
<li><a href="N-Ethylmaleimide.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Ethylmaleimide" title="N-Ethylmaleimide">NEM</a></li>
<li>Neoendorphins</li>
<li>Nepetalactone (catnip)</li>
<li><span class="new">Peptide B</span></li>
<li><span class="new">Peptide E</span></li>
<li><span class="new">Peptide F</span></li>
<li><span class="new">Peptide I</span></li>
<li>Rubiscolins</li>
<li><span class="new">Soymorphins</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Enkephalinase inhibitors:</i> Amastatin</li>
<li><span class="new">BL-2401</span></li>
<li><a href="Candoxatril.htm" tppabs="https://ptable.com/wiki/compounds/A/Candoxatril" title="Candoxatril">Candoxatril</a></li>
<li><a href="Phenylalanine.htm#D-,_L-_and_DL-phenylalanine" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine#D-,_L-_and_DL-phenylalanine" title="Phenylalanine"><span style="font-size:90%;">D </span>-Phenylalanine</a></li>
<li><span class="new">Dexecadotril (retorphan)</span></li>
<li>Ecadotril (sinorphan)</li>
<li>Kelatorphan</li>
<li><a href="Racecadotril.htm" tppabs="https://ptable.com/wiki/compounds/A/Racecadotril" title="Racecadotril">Racecadotril (acetorphan)</a></li>
<li>RB-101</li>
<li>RB-120</li>
<li>RB-3007</li>
<li><span class="new">Opiorphan</span></li>
<li>Selank</li>
<li>Semax</li>
<li>Spinorphin</li>
<li><a href="Thiorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiorphan" title="Thiorphan">Thiorphan</a></li>
<li>Tynorphin</li>
<li><a href="Ubenimex.htm" tppabs="https://ptable.com/wiki/compounds/A/Ubenimex" title="Ubenimex">Ubenimex (bestatin)</a></li></ul>

<ul><li><i>Propeptides:</i> β-Lipotropin (proendorphin)</li>
<li>Prodynorphin</li>
<li>Proenkephalin</li>
<li><span class="new">Pronociceptin</span></li>
<li>Proopiomelanocortin (POMC)</li></ul>

<ul><li><i>Others:</i> Kyotorphin (met-enkephalin releaser/degradation stabilizer)</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Receptor/signaling modulators • Signaling peptide/protein receptor modulators</i></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Sigma_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Sigma_receptor_modulators" style="font-size:114%;margin:0 4em">Sigma receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">σ<sub>1</sub></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Agonists:</b> 3-PPP</li>
<li>4-PPBP</li>
<li><a href="5-MeO-DMT.htm" tppabs="https://ptable.com/wiki/compounds/A/5-MeO-DMT" title="5-MeO-DMT">5-MeO-DMT</a></li>
<li>Alazocine (SKF-10047)</li>
<li><a href="Amantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amantadine" title="Amantadine">Amantadine</a></li>
<li>ANAVEX2-73</li>
<li>Arketamine</li>
<li><span class="new">BD-737</span></li>
<li>BD-1052</li>
<li>Captodiame</li>
<li><a href="Citalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Citalopram" title="Citalopram">Citalopram</a></li>
<li><abbr>CGRP</abbr></li>
<li>Cloperastine</li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Cutamesine (SA-4503)</li>
<li><a href="Cyclazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclazocine" title="Cyclazocine">Cyclazocine</a></li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">Dehydroepiandrosterone (DHEA)</a> (prasterone)</li>
<li><a href="Dehydroepiandrosterone_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone_sulfate" title="Dehydroepiandrosterone sulfate">Dehydroepiandrosterone sulfate (DHEA-S)</a> (prasterone sulfate)</li>
<li>Dextrallorphan</li>
<li><a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">Dextromethorphan (DXM)</a></li>
<li>Dextrorphan (DXO)</li>
<li>Dimemorfan</li>
<li><a href="Dimethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethyltryptamine" title="Dimethyltryptamine" class="mw-redirect">Dimethyltryptamine (DMT)</a></li>
<li>Ditolylguanidine (DTG)</li>
<li><a href="Donepezil.htm" tppabs="https://ptable.com/wiki/compounds/A/Donepezil" title="Donepezil">Donepezil</a></li>
<li>Eliprodil</li>
<li><a href="Escitalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Escitalopram" title="Escitalopram">Escitalopram</a></li>
<li>Fabomotizole (afobazole)</li>
<li><a href="Fluoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxetine" title="Fluoxetine">Fluoxetine</a></li>
<li><a href="Fluvoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluvoxamine" title="Fluvoxamine">Fluvoxamine</a></li>
<li>Ifenprodil</li>
<li>Igmesine (JO-1784)</li>
<li><span class="new">IPAB</span></li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>L-687384</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA"><abbr>MDMA</abbr> (midomafetamine)</a></li>
<li><a href="Memantine.htm" tppabs="https://ptable.com/wiki/compounds/A/Memantine" title="Memantine">Memantine</a></li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li>Methoxetamine</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li>
<li>Nepinalone</li>
<li>Neuropeptide Y</li>
<li><a href="Noscapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Noscapine" title="Noscapine">Noscapine</a></li>
<li><span class="new">OPC-14523</span></li>
<li>Opipramol</li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li><a href="Pentoxyverine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentoxyverine" title="Pentoxyverine">Pentoxyverine (carbetapentane)</a></li>
<li>PRE-084</li>
<li><a href="Pregnenolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregnenolone" title="Pregnenolone">Pregnenolone</a></li>
<li>Pregnenolone sulfate</li>
<li>Pridopidine</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Racemethorphan" title="Racemethorphan" class="mw-redirect">Racemethorphan (methorphan)</a></li>
<li>Racemorphan (morphanol)</li>
<li><span class="new">UMB-23</span></li>
<li><span class="new">UMB-82</span></li></ul>

<ul><li><b>Antagonists:</b> 3-PPP</li>
<li>AC-927</li>
<li>BD-1008</li>
<li>BD-1031</li>
<li>BD-1047</li>
<li>BD-1060</li>
<li>BD-1063</li>
<li>BD-1067</li>
<li>BMY-14802 (BMS-181100)</li>
<li>CM-156</li>
<li><span class="new">Dup-734</span></li>
<li><span class="new">E-5842</span></li>
<li>E-52862 (S1RA)</li>
<li><a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">Haloperidol</a></li>
<li><span class="new">LR-132</span></li>
<li><span class="new">LR-172</span></li>
<li><span class="new">MS-377</span></li>
<li>NE-100</li>
<li><span class="new">NPC-16377</span></li>
<li>Panamesine (EMD-57455)</li>
<li><span class="new">PD-144418</span></li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li><a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">Progesterone</a></li>
<li><a href="Rimcazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimcazole" title="Rimcazole">Rimcazole (BW-234U)</a></li>
<li><a href="Sertraline.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertraline" title="Sertraline">Sertraline</a></li>
<li><span class="new">SR-31742A</span></li></ul>

<ul><li><b>Allosteric modulators:</b> <a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">Phenytoin</a>; <i>Positive:</i> Methylphenylpiracetam</li>
<li><span class="new">SOMCL-668</span></li></ul>

<ul><li><b>Unknown/unsorted:</b> <span class="new">3-Methoxydextrallorphan</span></li>
<li>3-MeO-PCP</li>
<li>4C-T-2</li>
<li><span class="new">4-IBP</span></li>
<li><span class="new">4-IPBS</span></li>
<li>4-MeO-PCP</li>
<li>5-MeO-DALT</li>
<li>5-MeO-DiPT</li>
<li><a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">Amitriptyline</a></li>
<li><span class="new">Azidopamil</span></li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="Clemastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clemastine" title="Clemastine">Clemastine</a></li>
<li><a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">Clomipramine</a></li>
<li><a href="Clorgiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Clorgiline" title="Clorgiline">Clorgiline</a></li>
<li><small>D</small>-Deprenyl</li>
<li><abbr>DiPT</abbr></li>
<li><abbr>DPT</abbr></li>
<li>Ibogaine</li>
<li><a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">Imipramine</a></li>
<li><span class="new">KCR-12-83.1</span></li>
<li>Nemonapride</li>
<li>Noribogaine</li>
<li><span class="new">RHL-033</span></li>
<li>RS-67,333</li>
<li>RTI-55</li>
<li>Saffron</li>
<li>Safinamide</li>
<li><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">Selegiline</a></li>
<li><span class="new">Spipethiane</span></li>
<li><a href="Trifluoperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trifluoperazine" title="Trifluoperazine">Trifluoperazine</a></li>
<li>W-18</li>
<li>YKP10A</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">σ<sub>2</sub></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Agonists:</b> 3-PPP</li>
<li>Arketamine</li>
<li>BD-1047</li>
<li>BD1063</li>
<li>Ditolylguanidine (DTG)</li>
<li><span class="new">DKR-1005</span></li>
<li><span class="new">DKR-1051</span></li>
<li><a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">Haloperidol</a></li>
<li>Ifenprodil</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA"><abbr>MDMA</abbr> (midomafetamine)</a></li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li><span class="new">OPC-14523</span></li>
<li>Opipramol</li>
<li>PB-28</li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li>
<li>Siramesine (Lu 28-179)</li>
<li><span class="new">UKH-1114</span></li></ul>

<ul><li><b>Antagonists:</b> AC-927</li>
<li>BD-1008</li>
<li>BD-1067</li>
<li>CM-156</li>
<li><span class="new">CT-1812</span></li>
<li><span class="new">LR-172</span></li>
<li>MIN-101</li>
<li>Panamesine (EMD-57455)</li>
<li><span class="new">SAS-0132</span></li></ul>

<ul><li><b>Unknown/unsorted:</b> <span class="new">3-Methoxydextrallorphan</span></li>
<li>3-MeO-PCE</li>
<li>4-MeO-PCP</li>
<li>5-MeO-DALT</li>
<li>5-MeO-DiPT</li>
<li><a href="Clemastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clemastine" title="Clemastine">Clemastine</a></li>
<li><abbr>DiPT</abbr></li>
<li><abbr>DPT</abbr></li>
<li>Ibogaine</li>
<li>Nemonapride</li>
<li>Nepinalone</li>
<li>Noribogaine</li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li>RS-67,333</li>
<li>Safinamide</li>
<li><a href="Trimethoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4%2C5-Trimethoxyamphetamine" title="3,4,5-Trimethoxyamphetamine" class="mw-redirect"><abbr>TMA</abbr></a></li>
<li><span class="new">UMB-23</span></li>
<li><span class="new">UMB-82</span></li>
<li>W-18</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Unsorted</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Agonists:</b> <a href="Berberine.htm" tppabs="https://ptable.com/wiki/compounds/A/Berberine" title="Berberine">Berberine</a></li>
<li>Ethylketazocine</li>
<li>Fourphit</li>
<li>Metaphit</li>
<li>Naluzotan</li>
<li>Tapentadol</li>
<li><a href="Tenocyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tenocyclidine" title="Tenocyclidine">Tenocyclidine</a></li></ul>

<ul><li><b>Antagonists:</b> <span class="new">AHD1</span></li>
<li><span class="new">AZ66</span></li>
<li><a href="Lamotrigine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamotrigine" title="Lamotrigine">Lamotrigine</a></li>
<li><a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a></li>
<li><span class="new">SM-21</span></li>
<li><span class="new">UMB-100</span></li>
<li><span class="new">UMB-101</span></li>
<li><span class="new">UMB-103</span></li>
<li><span class="new">UMB-116</span></li>
<li><span class="new">YZ-011</span></li>
<li><span class="new">YZ-069</span></li>
<li><span class="new">YZ-185</span></li></ul>

<ul><li><b>Allosteric modulators:</b> SKF-83959</li></ul>

<ul><li><b>Unknown/unsorted:</b> 18-Methoxycoronaridine</li>
<li><span class="new">BMY-13980</span></li>
<li>Butaclamol</li>
<li>Caramiphen</li>
<li><span class="new">Carvotroline</span></li>
<li><a href="Chlorphenamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphenamine" title="Chlorphenamine">Chlorphenamine (chlorpheniramine)</a></li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="Cinnarizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cinnarizine" title="Cinnarizine">Cinnarizine</a></li>
<li><span class="new">Cinuperone</span></li>
<li>Clocapramine</li>
<li><a href="Dezocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dezocine" title="Dezocine">Dezocine</a></li>
<li><span class="new">EMD-59983</span></li>
<li>Hypericin (St. John's wort)</li>
<li><a href="Fluphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluphenazine" title="Fluphenazine">Fluphenazine</a></li>
<li>Gevotroline (WY-47384)</li>
<li><a href="Mepyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mepyramine" title="Mepyramine">Mepyramine (pyrilamine)</a></li>
<li><a href="Molindone.htm" tppabs="https://ptable.com/wiki/compounds/A/Molindone" title="Molindone">Molindone</a></li>
<li><a href="Perphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Perphenazine" title="Perphenazine">Perphenazine</a></li>
<li><a href="Pimozide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimozide" title="Pimozide">Pimozide</a></li>
<li>Proadifen</li>
<li><a href="Promethazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Promethazine" title="Promethazine">Promethazine</a></li>
<li><a href="Propranolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propranolol" title="Propranolol">Propranolol</a></li>
<li><a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">Quinidine</a></li>
<li><a href="Remoxipride.htm" tppabs="https://ptable.com/wiki/compounds/A/Remoxipride" title="Remoxipride">Remoxipride</a></li>
<li><span class="new">SL 82.0715</span></li>
<li><span class="new">SR-31747A</span></li>
<li>Tiospirone (BMY-13859)</li>
<li><a href="Venlafaxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Venlafaxine" title="Venlafaxine">Venlafaxine</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Receptor/signaling modulators</i></div></td></tr></tbody></table></div>















<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-03" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Naloxone&oldid=971023284  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Naloxone&oldid=971023284'" tppabs="https://en.wikipedia.org/wiki/?title=Naloxone&oldid=971023284">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>